Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A2M "CPAMD5, FWP007, S863-7" ENSG00000175899 Alpha-2-macroglobulin P01023 12 9067664-9116229 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 231.0;lung: 227.4" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 495.9;Hepatocytes: 596.0;Horizontal cells: 643.6;Ito cells: 555.5;Sertoli cells: 329.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.4" "Group enriched" "Detected in many" 7 "dendritic cells: 1.4;T-cells: 4.4" "Group enriched" "Detected in some" 5 "AF22: 113.6;ASC diff: 33.7;Hep G2: 91.5;SK-MEL-30: 32.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002265, CAB017621" Supported "Secreted to blood" NA NA 1630000000000 220000000000 "CAB017621: AB_1118894, HPA002265: AB_1078142" "unprognostic (1.73e-2)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (2.29e-2)" "unprognostic (7.36e-2)" "unprognostic (3.91e-2)" "unprognostic (7.95e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.19e-2)" "unprognostic (4.71e-2)" "unprognostic (2.06e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (2.32e-2)" "unprognostic (8.58e-2)" "unprognostic (9.03e-3)" 77.4 20.5 12.5 14.7 16.8 0.3 39.6 6.1 16.1 41.8 27.3 25.3 10.5 15.0 54.6 28.2 39.5 30.6 49.7 68.0 12.4 10.2 50.0 231.0 227.4 14.9 16.9 8.0 40.8 13.0 20.9 20.4 48.0 20.5 77.3 35.9 47.5 20.5 26.3 26.0 10.2 23.1 57.7 20.9 42.3 25.8 26.2 13.0 4.0 29.5 17.0 8.6 68.9 59.0 0.2 1.4 0.0 0.4 0.0 4.4 0.3 0.0 0.0 113.6 0.0 33.7 2.4 0.3 13.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 91.5 0.0 0.1 0.1 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 32.9 0.5 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.4 0.0 4.4 0.2 2.6 0.2 0.5 1.2 0.3 0.0 0.1 0.7 0.0 0.0 0.0 1.4 0.0 0.3 12.5 16.8 6.1 16.1 12.4 10.2 16.9 8.0 20.5 13.0 11.9 137.3 25.5 1.9 17.3 5.4 90.3 28.1 8.1 12.5 1.8 7.9 1.9 0.0 0.1 16.7 495.9 0.0 23.3 4.5 3.0 24.6 4.2 25.6 596.0 196.9 643.6 0.0 555.5 100.3 27.1 71.7 64.0 21.9 65.9 0.0 4.7 0.2 0.0 133.0 0.0 18.6 329.8 207.9 1.8 1.1 12.3 3.4 16.7 0.0 2.2 ABCA8 KIAA0822 ENSG00000141338 "ATP binding cassette subfamily A member 8" O94911 17 68867292-68955392 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Leydig cells: 465.4;Muller glia cells: 138.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 16.6;ASC TERT1: 37.0;HSkMC: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044914 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044914: AB_10964859" "unprognostic (2.58e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.04e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (5.22e-2)" "unprognostic (6.68e-2)" "unprognostic (8.76e-2)" "unprognostic (1.42e-3)" "unprognostic (3.52e-3)" "unprognostic (1.88e-1)" "unprognostic (3.29e-1)" "unprognostic (6.14e-3)" 29.1 25.2 10.0 3.4 27.2 0.5 15.1 3.2 15.4 7.3 12.8 29.9 3.9 5.4 10.2 13.0 12.4 17.6 14.3 30.0 12.5 5.5 8.1 26.6 15.2 1.3 37.8 9.2 44.7 5.1 4.5 14.8 7.6 22.2 10.3 14.3 16.4 9.8 7.9 8.9 4.9 9.9 7.1 28.2 9.9 11.5 15.8 42.7 0.0 13.0 14.2 2.8 13.6 20.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 16.6 37.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.1 0.0 0.0 27.9 0.0 0.4 0.0 0.2 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.0 27.2 3.2 15.4 12.5 5.5 37.8 9.2 22.2 42.7 47.6 0.6 0.0 1.3 5.4 1.4 12.5 0.0 0.0 7.9 0.0 2.0 0.1 0.0 0.0 4.2 4.2 0.0 0.0 0.0 0.1 35.3 0.3 1.1 35.8 0.9 4.8 0.0 7.4 1.9 4.3 465.4 1.8 1.7 0.0 0.0 138.5 0.0 0.0 66.1 0.0 2.1 38.8 6.2 1.1 1.2 4.1 0.2 0.0 0.0 0.2 ABCA9 EST640918 ENSG00000154258 "ATP binding cassette subfamily A member 9" Q8IUA7 17 68974488-69061064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 42.5" "Cell type enhanced" "Detected in many" 22 "Ito cells: 26.4;Leydig cells: 89.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "ASC diff: 14.5;ASC TERT1: 31.1;HSkMC: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052113, HPA054823" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA052113: AB_2732573, HPA054823: AB_2682615" "unprognostic (3.88e-2)" "unprognostic (9.86e-2)" "unprognostic (2.21e-1)" "unprognostic (9.75e-2)" "unprognostic (4.46e-1)" "unprognostic (5.64e-3)" "unprognostic (4.51e-4)" "unprognostic (1.83e-2)" "unprognostic (1.94e-3)" "unprognostic (7.86e-2)" "unprognostic (3.26e-3)" "unprognostic (3.51e-1)" "unprognostic (7.77e-6)" "unprognostic (5.32e-4)" "unprognostic (7.22e-2)" "unprognostic (1.84e-2)" "unprognostic (4.96e-3)" 42.5 4.2 1.2 5.5 2.8 1.7 14.1 2.7 2.6 13.4 17.4 2.6 6.8 1.7 15.5 11.8 25.5 8.8 7.2 15.0 2.1 1.9 2.5 7.6 5.6 2.1 7.8 2.0 25.2 2.3 1.7 2.8 1.1 4.4 13.9 3.8 4.1 5.7 4.7 12.4 5.4 3.7 11.9 3.8 1.6 4.8 10.9 2.1 1.0 7.6 9.9 2.5 20.4 18.7 1.8 0.9 2.9 0.8 1.2 1.3 0.0 0.2 0.4 0.5 0.6 14.5 31.1 0.5 0.3 0.3 0.0 0.2 0.4 0.4 0.4 0.1 0.5 0.3 0.4 0.3 0.5 0.2 0.2 0.4 0.5 1.3 0.4 1.6 0.6 0.9 11.1 0.4 2.3 0.2 0.6 3.1 0.4 0.5 1.1 0.2 0.2 0.2 1.4 0.3 0.1 0.3 1.5 0.1 0.2 0.1 1.3 0.6 0.5 0.4 0.3 0.3 0.4 0.3 0.5 1.3 0.9 0.4 1.7 0.3 1.0 0.3 0.3 0.3 0.3 1.5 1.7 0.8 1.4 1.3 0.6 1.3 1.1 0.8 0.5 0.9 1.8 1.3 1.3 2.9 1.2 0.5 0.7 0.4 0.0 1.2 2.8 2.7 2.6 2.1 1.9 7.8 2.0 4.4 2.1 0.0 1.0 0.0 0.2 1.5 5.4 2.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.4 0.0 0.0 0.0 10.6 0.1 0.0 9.9 0.2 0.0 0.0 26.4 1.8 2.1 89.2 0.6 0.0 0.0 0.0 12.1 0.3 0.0 14.5 0.0 6.1 12.9 1.4 1.2 0.6 1.4 0.0 0.0 0.0 0.1 ABCD2 "ALDL1, ALDR, ALDRP" ENSG00000173208 "ATP binding cassette subfamily D member 2" Q9UBJ2 12 39550033-39619751 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 24.1;brain: 30.1" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 55.5" "Cancer enriched" "Detected in single" 7 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Group enriched" "Detected in some" 5 "ASC diff: 9.2;HDLM-2: 12.4;Karpas-707: 22.2;SH-SY5Y: 13.4;U-266/70: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-3)" "unprognostic (4.06e-4)" "unprognostic (9.27e-2)" "unprognostic (1.15e-2)" "unprognostic (2.06e-1)" "unprognostic (7.31e-5)" "unprognostic (3.42e-2)" "unprognostic (2.90e-2)" "unprognostic (8.06e-3)" "unprognostic (3.43e-2)" "unprognostic (1.24e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-4)" "unprognostic (5.04e-2)" "unprognostic (8.04e-2)" "unprognostic (1.13e-1)" "unprognostic (6.74e-2)" 24.1 3.6 6.8 3.5 6.8 0.9 5.5 30.1 13.4 10.6 1.7 1.3 0.0 1.4 5.4 1.0 1.3 5.2 1.4 7.4 5.1 4.1 1.4 0.7 1.4 4.8 4.8 8.4 0.7 0.7 0.7 5.1 0.5 11.4 1.2 1.7 2.9 4.6 1.6 0.7 0.7 1.7 5.1 2.1 3.0 1.6 0.9 2.6 0.9 1.0 0.6 3.2 2.8 1.9 0.8 0.8 0.1 0.0 1.4 6.5 1.8 0.0 0.0 0.1 0.0 9.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.4 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.5 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 1.9 0.8 4.3 5.7 0.2 0.4 5.0 6.5 0.1 1.4 0.0 0.8 5.1 1.8 6.8 6.8 30.1 13.4 5.1 4.1 4.8 8.4 11.4 2.6 0.0 0.0 0.8 0.0 0.0 55.5 8.9 0.0 4.0 0.0 0.0 5.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.7 0.0 0.0 0.7 0.5 1.8 0.0 0.3 0.1 0.0 0.0 0.0 3.5 0.0 0.0 AC025165.3 ENSG00000257921 12 57773028-57787046 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 14.2;salivary gland: 16.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "glioma: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "ASC diff: 3.7;fHDF/TERT166: 1.7;HMC-1: 2.0;Karpas-707: 1.8;RH-30: 4.7" NA NA "unprognostic (1.28e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.88e-1)" "unprognostic (1.38e-4)" "unprognostic (3.74e-2)" "unprognostic (6.78e-4)" "unprognostic (2.19e-2)" "unprognostic (2.05e-1)" "unprognostic (8.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.55e-1)" "unprognostic (3.46e-2)" "unprognostic (6.73e-2)" "unprognostic (1.74e-2)" 3.0 1.2 1.4 0.8 1.3 0.8 3.4 1.4 1.5 2.4 1.3 0.0 2.8 0.8 3.3 2.3 1.7 0.8 2.5 0.8 0.9 1.0 3.7 1.7 2.1 3.3 1.2 0.1 3.6 14.2 0.8 0.8 0.9 0.4 2.3 2.0 1.6 16.5 5.3 0.8 0.8 0.8 2.0 2.5 0.8 1.0 1.0 0.0 0.0 2.4 1.1 1.7 2.3 0.7 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 1.4 1.5 0.9 1.0 1.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACSM5 FLJ20581 ENSG00000183549 "Acyl-CoA synthetase medium chain family member 5" Q6NUN0 16 20409534-20441336 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 94.6" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 179.6" "Group enriched" "Detected in some" 7 "liver cancer: 20.5;renal cancer: 9.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 8 "dendritic cells: 3.2;monocytes: 2.8" "Group enriched" "Detected in some" 5 "ASC diff: 5.8;ASC TERT1: 12.6;HSkMC: 15.0;U-87 MG: 9.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041435 Uncertain Uncertain Vesicles NA NA Vesicles "HPA041435: AB_10961121" "unprognostic (1.01e-1)" "unprognostic (1.61e-3)" "unprognostic (3.73e-2)" "unprognostic (1.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-2)" "unprognostic (1.84e-2)" "unprognostic (4.64e-3)" "unprognostic (1.64e-1)" "unprognostic (2.01e-2)" "unprognostic (2.15e-2)" "unprognostic (2.33e-1)" "unprognostic (5.11e-3)" "unprognostic (2.09e-2)" "unprognostic (3.85e-2)" "unprognostic (2.78e-2)" "unprognostic (1.57e-1)" 11.1 1.1 1.9 0.7 2.1 0.4 3.2 1.3 1.6 1.0 1.0 2.9 0.0 0.5 0.3 2.8 0.5 0.6 1.0 0.9 3.0 1.9 8.9 94.6 0.9 1.6 2.9 2.1 0.4 1.4 0.4 0.1 0.7 2.0 0.4 0.6 0.5 0.5 0.5 4.4 0.6 0.6 0.5 2.9 1.7 0.9 1.0 3.0 0.1 1.7 0.6 0.4 0.5 0.7 0.3 3.2 0.3 2.8 0.0 0.3 0.5 0.0 0.0 0.1 0.1 5.8 12.6 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 15.0 0.0 0.8 0.1 0.3 0.0 0.0 0.1 0.6 1.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 9.2 0.1 0.0 0.3 2.8 0.1 0.1 1.9 0.1 0.1 0.3 0.2 3.2 0.3 0.2 0.3 0.1 0.0 1.3 0.1 0.0 0.5 1.9 2.1 1.3 1.6 3.0 1.9 2.9 2.1 2.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.0 179.6 3.3 0.0 0.0 6.7 8.8 0.2 8.6 1.2 0.0 1.8 0.0 1.1 0.0 0.0 5.6 31.5 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.1 ACVR1C "ACVRLK7, ALK7" ENSG00000123612 "Activin A receptor type 1C" Q8NER5 2 157526767-157629005 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 36.2;breast: 15.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 11.4;Leydig cells: 29.4;Paneth cells: 10.4;Undifferentiated cells: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Group enriched" "Detected in some" 4 "ASC diff: 15.4;HDLM-2: 6.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6" "HPA007982, HPA011933" Approved "Intracellular and membrane" NA NA "HPA007982: AB_1078134, HPA011933: AB_1844754" "unprognostic (1.03e-1)" "unprognostic (4.55e-2)" "unprognostic (9.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (1.00e-1)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (7.12e-3)" "unprognostic (3.62e-1)" "unprognostic (9.31e-6)" "unprognostic (7.28e-2)" "unprognostic (1.95e-1)" "unprognostic (9.74e-2)" "unprognostic (1.30e-1)" 36.2 3.7 3.9 2.7 10.3 0.7 15.3 1.6 4.4 0.9 9.4 2.7 0.0 5.5 0.7 1.0 0.8 0.8 1.8 1.0 9.2 3.1 1.1 3.3 0.8 1.2 3.7 3.1 5.1 2.4 0.5 12.0 0.7 3.5 0.9 4.4 0.0 1.5 1.0 1.3 0.7 4.4 0.8 2.8 0.8 3.4 1.1 4.0 0.0 0.9 0.5 1.0 0.6 2.9 0.6 0.0 0.0 0.0 0.0 2.8 0.4 2.0 0.0 0.0 0.2 15.4 0.5 0.3 0.4 0.4 0.1 0.5 2.3 0.2 0.0 0.2 1.2 1.0 0.0 0.1 0.0 0.3 6.8 1.0 0.0 0.0 0.5 0.0 0.0 1.2 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.3 0.0 0.0 1.4 0.1 0.7 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.3 0.0 0.3 0.0 0.8 0.2 0.0 0.2 0.8 2.4 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.5 0.0 1.0 0.6 1.8 1.2 0.0 0.5 2.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 3.9 10.3 1.6 4.4 9.2 3.1 3.7 3.1 3.5 4.0 0.0 0.6 0.0 0.9 0.6 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 1.1 1.0 11.4 0.0 0.2 0.3 1.2 0.8 0.0 4.7 0.1 0.0 7.5 0.0 0.0 0.4 29.4 0.0 3.3 7.2 8.4 1.0 0.4 10.4 8.5 0.7 0.0 0.0 1.0 0.0 2.0 1.3 0.2 0.0 12.1 0.4 ADRA1A "ADRA1C, ADRA1L1" ENSG00000120907 "Adrenoceptor alpha 1A" P35348 8 26748150-26867273 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.1" "Group enriched" "Detected in some" 15 "Early spermatids: 50.8;Hepatocytes: 14.0;Late spermatids: 20.6" "Cancer enhanced" "Detected in some" "liver cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 1.3;HAP1: 1.7;JURKAT: 2.0;NTERA-2: 2.3;U-2 OS: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029678, HPA029679, HPA076693" Approved Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: " "unprognostic (1.27e-1)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (3.57e-1)" "unprognostic (5.04e-4)" "unprognostic (1.97e-1)" "unprognostic (9.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.58e-2)" "unprognostic (7.47e-2)" "unprognostic (1.71e-2)" "unprognostic (6.06e-3)" "unprognostic (7.41e-2)" "unprognostic (1.52e-2)" "unprognostic (1.30e-1)" 14.5 0.7 7.1 1.1 3.9 0.3 3.4 6.2 4.9 0.9 1.5 5.9 4.9 1.0 1.8 2.0 0.9 0.6 0.5 10.1 11.6 2.0 0.8 45.1 3.9 1.4 4.7 4.7 1.0 0.5 0.3 0.6 0.3 3.8 10.2 0.7 0.6 4.6 11.2 0.6 0.9 1.3 2.4 1.9 7.0 1.2 0.5 4.2 0.0 0.6 0.1 0.6 0.6 0.7 0.3 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 7.1 3.9 6.2 4.9 11.6 2.0 4.7 4.7 3.8 4.2 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.3 0.0 20.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 145.9;tongue: 74.5" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8" "Cancer enhanced" "Detected in many" "liver cancer: 64.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 8 "ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: AB_2685966" "unprognostic (1.54e-2)" "prognostic favorable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favorable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 52.0 3.8 2.1 3.4 4.1 1.4 36.0 2.6 2.7 2.2 3.2 2.6 1.2 6.2 1.4 4.0 19.2 1.7 16.1 22.1 2.6 2.6 32.0 145.9 11.2 2.5 5.4 1.4 3.8 4.9 0.6 4.1 0.7 6.6 5.1 3.2 3.8 13.1 3.4 17.1 4.7 4.6 4.8 6.8 0.9 21.9 5.2 3.2 0.0 11.5 74.5 5.0 17.4 10.8 0.0 0.9 4.2 0.1 0.3 1.7 0.8 0.0 25.5 0.1 25.7 185.8 22.4 0.0 0.8 5.7 0.3 0.2 0.4 0.0 0.0 0.3 5.7 4.4 0.2 0.0 1.3 0.1 0.0 0.0 0.7 4.1 315.1 1.8 0.1 0.0 11.4 1.6 2.6 1.6 0.0 0.6 0.1 5.4 0.0 4.4 0.1 0.0 0.0 0.0 134.5 0.0 0.0 0.0 0.2 1.4 4.8 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.4 5.0 2.2 0.1 5.9 0.2 0.1 0.0 0.0 7.9 0.7 0.0 4.2 0.1 1.1 1.7 0.0 0.1 0.0 0.7 0.4 0.2 0.0 0.3 1.5 0.9 0.3 0.0 0.9 0.4 0.8 2.1 4.1 2.6 2.7 2.6 2.6 5.4 1.4 6.6 3.2 62.5 27.2 1.5 11.8 18.8 2.5 2.4 239.5 96.4 128.5 59.3 0.0 0.0 11.6 33.9 14.9 17.8 9.3 70.0 290.3 0.0 13.4 11.4 4.6 511.8 0.3 0.0 1.7 26.4 14.5 8.0 140.4 3.8 101.3 8.2 1.7 47.9 184.6 0.9 138.6 40.8 4.3 0.0 14.4 1.7 0.7 17.9 0.1 0.9 2.6 140.8 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.9;liver: 122.7;tongue: 111.8" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 135.0;Hepatocytes: 341.7;Pancreatic endocrine cells: 140.7" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Group enriched" "Detected in some" 4 "A549: 130.6;ASC diff: 162.1;Hep G2: 243.7;OE19: 168.2;RT4: 74.6" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: AB_2685966" "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 60.4 4.0 1.8 2.0 3.3 0.0 71.9 2.5 2.1 1.3 2.9 1.0 1.2 5.5 1.0 3.0 17.4 1.5 19.4 9.3 1.7 2.3 4.8 122.7 5.9 1.1 4.7 0.9 1.9 2.4 0.0 1.8 0.1 4.2 8.1 2.4 2.0 12.0 2.4 19.8 4.2 2.4 4.4 3.9 0.6 26.2 2.3 2.6 0.1 4.2 111.8 5.5 25.3 11.9 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 130.6 0.1 13.8 162.1 5.6 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.7 0.9 0.6 3.6 0.0 0.6 0.0 0.0 0.0 0.0 36.8 243.7 0.3 0.0 0.0 14.5 8.2 0.6 0.6 0.0 0.0 0.0 5.0 0.0 1.3 0.2 0.0 0.0 0.0 168.2 0.0 0.0 0.0 2.1 1.2 74.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.1 4.8 0.0 0.0 0.0 0.0 1.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 3.3 2.5 2.1 1.7 2.3 4.7 0.9 4.2 2.6 11.9 3.2 0.0 3.2 10.5 1.8 3.7 135.0 18.7 19.4 0.0 0.0 0.0 0.0 12.3 18.3 8.7 9.3 0.0 93.5 0.1 15.0 4.5 0.0 341.7 0.1 3.2 1.7 12.3 13.7 5.6 73.4 1.1 8.5 1.0 2.8 33.8 140.7 7.0 73.9 2.6 2.6 0.0 7.6 0.3 0.3 11.8 0.0 1.3 7.4 79.1 ANGPT4 ENSG00000101280 "Angiopoietin 4" Q9Y264 20 869899-916317 "Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.7;breast: 12.3;cervix, uterine: 16.8" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 21.4;Late spermatids: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 40 "ASC diff: 21.6;BEWO: 30.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB013260, CAB013305" Uncertain "Secreted to blood" NA NA "CAB013260: , CAB013305: " "unprognostic (1.77e-1)" "unprognostic (3.25e-1)" "unprognostic (4.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.37e-2)" "unprognostic (3.41e-1)" "unprognostic (5.82e-4)" "unprognostic (1.25e-1)" "unprognostic (7.10e-2)" "unprognostic (3.66e-4)" "unprognostic (9.01e-2)" "unprognostic (1.71e-1)" "unprognostic (5.25e-2)" "unprognostic (1.23e-2)" "unprognostic (1.55e-1)" "unprognostic (2.95e-4)" "unprognostic (9.14e-2)" 18.7 0.7 0.1 0.1 0.3 0.1 12.3 0.0 0.5 16.8 1.4 0.6 2.1 0.2 7.1 4.9 1.2 3.5 2.5 1.1 0.1 0.3 0.4 0.1 2.6 0.1 0.3 0.0 4.8 0.2 0.1 0.0 0.4 0.3 1.8 0.1 2.4 1.3 2.2 0.2 1.4 0.3 2.6 0.1 0.1 0.4 3.7 0.0 0.0 2.1 1.6 0.4 1.3 2.2 0.3 0.6 2.4 0.9 0.2 0.3 0.5 0.1 0.0 0.0 0.0 21.6 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.9 0.4 0.2 0.5 0.0 0.1 0.2 0.3 0.6 0.3 0.1 0.2 0.8 0.2 0.6 0.2 0.0 0.5 0.1 0.3 0.0 0.5 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 0.1 0.0 0.0 0.0 21.4 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 13.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 1.1 0.0 0.0 0.0 ANGPTL1 "ANG3, ANGPT3, AngY, ARP1" ENSG00000116194 "Angiopoietin like 1" O95841 1 178849705-178871052 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Leydig cells: 394.4;Peritubular cells: 199.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.3;naive B-cell: 2.9" "Lineage enhanced" "Detected in single" "B-cells: 2.9" "Group enriched" "Detected in some" 18 "ASC diff: 48.7;ASC TERT1: 19.6;HHSteC: 21.1;HSkMC: 48.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009976 Approved "Secreted to blood" NA NA 100000 "HPA009976: AB_1844822" "unprognostic (2.59e-2)" "unprognostic (1.31e-1)" "unprognostic (5.80e-3)" "unprognostic (2.63e-2)" "unprognostic (3.60e-1)" "unprognostic (1.71e-2)" "prognostic favorable (8.73e-4)" "unprognostic (3.81e-2)" "unprognostic (5.78e-3)" "unprognostic (1.47e-1)" "unprognostic (1.39e-1)" "unprognostic (5.31e-2)" "prognostic favorable (5.11e-4)" "unprognostic (1.49e-2)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.61e-3)" 17.7 16.3 1.2 8.5 1.1 0.0 14.4 0.7 1.4 26.3 36.2 0.9 9.6 2.6 34.6 46.5 33.6 29.7 16.6 12.9 1.0 0.6 15.9 7.1 12.4 15.8 0.6 2.5 35.7 6.4 0.0 2.2 42.0 1.6 16.7 8.7 0.9 14.2 4.2 20.0 4.5 28.2 22.7 1.8 7.0 13.1 24.7 0.4 0.9 19.3 57.5 2.8 25.5 13.7 2.9 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 48.7 19.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 21.1 0.0 0.0 48.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.9 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 1.1 0.7 1.4 1.0 0.6 0.6 2.5 1.6 0.4 0.0 0.0 0.5 0.0 3.3 2.2 3.1 30.6 1.4 0.0 1.8 5.9 0.5 1.7 0.7 0.8 2.9 0.0 0.0 0.4 0.6 51.8 0.1 0.0 0.9 1.3 0.0 0.0 11.6 0.0 1.9 394.4 0.0 3.3 0.0 0.0 36.6 0.0 0.0 199.4 0.0 12.4 38.8 35.0 0.7 0.7 3.1 1.1 0.0 0.0 0.1 ANGPTL5 ENSG00000187151 "Angiopoietin like 5" Q86XS5 11 101890674-101916522 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.4;ovary: 24.9" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 5.6;Leydig cells: 25.6;Melanocytes: 6.8;Peritubular cells: 14.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "ASC diff: 7.9;ASC TERT1: 2.2" "Low region specificity" "Detected in all" HPA038516 Uncertain "Secreted in other tissues" NA NA "HPA038516: AB_10672749" "unprognostic (8.28e-3)" "unprognostic (3.08e-2)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (3.23e-2)" "unprognostic (2.18e-1)" "unprognostic (4.88e-2)" "unprognostic (6.74e-4)" "unprognostic (1.96e-1)" "unprognostic (1.53e-8)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-3)" 9.4 0.3 0.2 0.0 0.3 0.0 6.4 0.2 0.7 1.3 0.3 0.0 0.6 0.1 0.1 5.0 1.0 0.4 0.3 3.7 0.2 0.2 0.1 0.2 1.0 0.1 2.0 0.5 24.9 0.0 0.0 0.3 0.1 0.8 1.4 0.2 0.0 0.5 0.3 1.9 3.5 0.5 1.3 1.7 0.0 0.2 6.2 0.3 0.2 2.4 2.9 0.0 1.8 1.1 0.7 1.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.0 7.9 2.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.9 0.0 1.0 0.0 0.0 0.2 0.3 0.2 0.7 0.2 0.2 2.0 0.5 0.8 0.3 0.0 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 25.6 0.0 6.8 0.0 0.0 0.2 0.0 0.0 14.2 0.0 0.3 0.0 1.4 0.2 0.0 4.8 0.1 0.0 0.0 0.0 APOD ENSG00000189058 "Apolipoprotein D" P05090 3 195568702-195584205 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "breast: 840.7" "Group enriched" "Detected in many" 5 "Leydig cells: 1923.5;Melanocytes: 975.2;Peritubular cells: 934.8" "Cancer enhanced" "Detected in all" "melanoma: 925.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory B-cell: 6.7" "Lineage enriched" "Detected in single" 10 "B-cells: 6.7" "Group enriched" "Detected in some" 7 "ASC diff: 239.5;ASC TERT1: 129.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040520 Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 98900000000 220000000000 "Plasma membrane" "HPA040520: AB_2677020" "prognostic favorable (5.51e-4)" "unprognostic (7.62e-3)" "unprognostic (7.85e-3)" "unprognostic (3.34e-3)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.38e-1)" "unprognostic (3.19e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.71e-3)" 134.4 15.2 39.7 5.7 39.9 3.4 840.7 14.7 66.1 75.0 16.4 79.7 10.9 12.9 36.6 30.0 46.1 42.9 36.4 124.7 45.5 29.2 8.5 3.5 11.8 6.5 96.9 28.2 19.4 28.3 9.0 14.3 59.6 50.9 39.7 13.1 99.1 152.5 35.1 110.4 66.0 7.2 30.4 81.6 3.6 28.7 32.0 56.5 0.0 87.7 42.2 6.6 62.1 95.7 6.7 0.1 0.4 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 239.5 129.1 0.3 2.0 0.5 0.0 0.0 13.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 6.5 1.4 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 2.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 25.9 0.4 0.1 0.0 0.1 0.1 0.0 6.7 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 39.7 39.9 14.7 39.5 45.5 29.2 96.9 28.2 50.9 56.5 0.0 8.3 0.0 14.6 128.8 0.0 31.1 0.0 40.2 104.6 5.2 0.0 4.1 0.0 0.2 9.1 55.0 0.0 0.0 0.0 5.0 271.0 22.1 0.0 0.0 12.4 0.0 44.5 30.1 0.3 22.5 1923.5 6.2 975.2 1.8 0.9 0.0 1.9 0.0 934.8 0.1 0.0 19.4 80.9 3.8 3.8 89.6 4.9 0.0 0.6 37.7 AVPR1A AVPR1 ENSG00000166148 "Arginine vasopressin receptor 1A" P37288 12 63142759-63150942 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 34.9;liver: 71.2" "Group enriched" "Detected in some" 9 "Hepatocytes: 50.5;Sertoli cells: 77.6;Smooth muscle cells: 34.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "ASC diff: 6.9;Karpas-707: 15.4;U-266/84: 10.7" "Group enriched" "Detected in some" 5 "basal ganglia: 7.1;hypothalamus: 4.4" "Low region specificity" "Detected in all" NA NA "unprognostic (1.49e-1)" "unprognostic (2.82e-1)" "unprognostic (9.90e-3)" "unprognostic (2.90e-1)" "unprognostic (1.59e-1)" "unprognostic (1.43e-3)" "unprognostic (3.79e-2)" "unprognostic (2.60e-1)" "unprognostic (3.58e-6)" "unprognostic (1.45e-1)" "unprognostic (7.29e-2)" "unprognostic (1.55e-1)" "unprognostic (1.38e-3)" "unprognostic (4.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.77e-2)" "unprognostic (4.66e-4)" 26.4 34.9 0.3 2.8 0.3 0.0 6.3 0.2 0.4 9.7 4.2 0.5 1.1 0.2 16.5 2.1 2.5 3.7 3.4 2.5 0.3 0.3 4.2 71.2 0.7 1.5 0.3 0.0 3.8 1.5 1.1 1.0 1.2 0.6 3.2 0.5 0.5 1.1 2.4 4.4 1.3 0.8 7.5 0.3 0.5 1.5 1.8 0.0 0.6 6.1 3.0 0.4 6.2 2.6 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.2 0.3 0.7 0.0 6.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.3 0.3 0.2 0.4 0.3 0.3 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.0 0.1 3.2 2.5 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 50.5 0.2 0.0 0.0 0.6 1.3 0.0 2.6 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.3 77.6 34.1 0.2 0.2 0.3 0.1 0.0 0.0 0.3 C1QTNF7 CTRP7 ENSG00000163145 "C1q and TNF related 7" Q9BXJ2 4 15339818-15446166 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 39.6" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 15.1;Fibroblasts: 10.3;Leydig cells: 21.0;Peritubular cells: 29.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.7" "Group enriched" "Detected in some" 5 "ASC diff: 9.2;ASC TERT1: 6.4;HSkMC: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB007055, HPA051797, HPA055392" Uncertain Approved Vesicles "Secreted to blood" NA NA 238000000 Vesicles "CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596" "unprognostic (6.61e-2)" "unprognostic (4.50e-2)" "unprognostic (6.16e-2)" "unprognostic (6.50e-4)" "unprognostic (1.24e-1)" "unprognostic (4.98e-3)" "unprognostic (2.31e-2)" "unprognostic (7.69e-3)" "unprognostic (7.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.97e-4)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (7.56e-3)" "unprognostic (7.28e-3)" 16.0 0.9 0.6 24.7 0.8 0.0 7.4 0.3 0.7 39.6 12.0 0.5 3.3 0.6 24.6 10.1 17.3 6.2 20.3 5.4 0.6 0.6 4.0 1.0 7.9 0.5 0.8 0.5 15.9 1.3 0.0 1.4 5.4 0.8 22.0 3.2 5.4 2.7 2.4 2.2 3.5 4.1 22.1 0.7 10.2 10.4 4.4 0.1 0.3 4.2 13.0 2.0 16.3 15.8 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 6.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3.4 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.3 0.7 0.6 0.6 0.8 0.5 0.8 0.1 0.0 0.0 0.0 0.0 3.2 15.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 10.3 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 21.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 29.7 1.0 0.9 6.5 8.2 0.0 0.0 2.6 0.0 0.0 0.0 0.1 C6 ENSG00000039537 "Complement C6" P13671 5 41142234-41261438 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Complement pathway, Cytolysis, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 176.1" "Group enriched" "Detected in some" 7 "Cholangiocytes: 132.5;Ciliated cells: 99.0;Hepatocytes: 342.0;Leydig cells: 111.4" "Group enriched" "Detected in many" 7 "liver cancer: 49.0;pancreatic cancer: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "ASC diff: 5.2;ASC TERT1: 7.3;HSkMC: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043823, CAB069427" Enhanced "Secreted to blood" NA NA 7600000000 "CAB069427: AB_1614336, HPA043823: AB_10960262" "unprognostic (9.79e-2)" "unprognostic (1.96e-2)" "unprognostic (5.94e-3)" "unprognostic (3.02e-2)" "unprognostic (1.67e-1)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (4.66e-2)" "unprognostic (3.72e-2)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (3.04e-3)" "prognostic favorable (4.31e-4)" "unprognostic (2.69e-4)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" 2.3 0.1 0.2 0.1 0.2 0.0 1.0 0.1 0.2 0.3 0.5 0.5 0.1 0.1 0.2 2.7 0.3 8.8 2.4 24.1 0.2 0.0 5.2 176.1 0.9 0.8 0.1 0.1 3.2 10.1 0.0 0.4 0.4 0.6 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.8 0.1 0.2 0.1 0.4 1.7 0.1 0.1 0.4 0.7 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.6 0.1 0.0 0.0 3.9 0.0 0.0 0.0 16.8 132.5 99.0 13.6 0.0 0.0 0.0 0.0 4.4 8.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 342.0 0.0 0.0 0.0 3.7 8.6 25.4 111.4 0.1 0.0 0.0 0.0 0.0 0.9 0.2 0.4 0.8 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 C7 ENSG00000112936 "Complement C7" P10643 5 40909252-40982939 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 199.9" "Group enriched" "Detected in many" 11 "Ito cells: 387.4;Leydig cells: 980.0;Sertoli cells: 304.0" "Cancer enhanced" "Detected in all" "pancreatic cancer: 73.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "ASC diff: 38.5;HHSteC: 50.9;HSkMC: 70.0;SH-SY5Y: 47.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA001465 Approved "Secreted to blood" NA NA 67000000000 "HPA001465: AB_1078554" "unprognostic (5.01e-2)" "unprognostic (3.74e-2)" "unprognostic (7.40e-2)" "unprognostic (4.68e-3)" "unprognostic (5.35e-2)" "unprognostic (1.43e-3)" "prognostic favorable (5.89e-4)" "unprognostic (6.67e-2)" "unprognostic (3.45e-1)" "unprognostic (2.21e-2)" "unprognostic (1.33e-1)" "unprognostic (1.93e-3)" "unprognostic (2.24e-2)" "unprognostic (6.10e-3)" "unprognostic (1.12e-1)" "unprognostic (2.14e-1)" "unprognostic (2.06e-3)" 54.4 99.5 0.8 7.4 1.6 0.0 10.5 1.1 1.0 30.2 34.7 3.1 14.8 2.5 36.8 48.6 55.3 47.7 48.2 79.7 0.9 0.3 81.3 41.0 29.1 69.0 3.9 1.5 199.9 32.4 3.0 5.2 55.4 3.7 52.5 4.8 1.4 5.1 17.5 1.9 1.8 17.0 43.3 3.2 33.6 17.9 44.6 0.7 3.1 32.4 1.1 7.2 39.9 29.6 0.7 0.4 1.6 0.3 1.5 0.4 0.0 0.0 0.0 0.0 0.0 38.5 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.9 0.0 0.0 70.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 47.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.2 0.3 0.1 0.2 0.2 0.2 0.0 0.7 0.3 0.4 1.1 1.5 0.3 0.4 0.0 0.0 0.8 1.6 1.1 1.0 0.9 0.3 3.9 1.5 3.7 0.7 6.0 5.5 0.0 0.2 0.6 0.5 39.5 7.6 0.0 4.5 0.0 0.0 0.2 0.0 0.2 2.5 13.1 0.0 0.0 1.2 0.0 17.7 0.6 1.1 2.4 0.4 41.3 52.7 387.4 14.9 7.4 980.0 1.6 0.0 1.0 0.0 4.5 0.9 0.0 17.0 0.0 0.7 304.0 5.1 2.3 1.3 0.5 0.2 0.0 1.9 0.5 CD36 "FAT, GP3B, GP4, GPIV, SCARB3" ENSG00000135218 "CD36 molecule" P16671 7 80369575-80679277 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Transport" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 464.3;breast: 156.1" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 491.8;Hofbauer cells: 1111.0;Ito cells: 465.9;Sertoli cells: 685.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9" "Group enriched" "Detected in many" 45 "dendritic cells: 56.9;monocytes: 104.4" "Group enriched" "Detected in some" 5 "ASC diff: 82.7;HEL: 39.3" "Low region specificity" "Detected in many" "HPA002018, CAB025866, HPA071026" Enhanced Enhanced "Golgi apparatus" NA NA 92000000 "Golgi apparatus" "CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170" "unprognostic (7.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.06e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (9.35e-2)" "unprognostic (2.64e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (7.05e-3)" "unprognostic (4.87e-2)" "unprognostic (2.73e-3)" 464.3 3.6 1.2 8.9 1.3 10.9 156.1 0.5 0.5 1.8 31.8 0.6 3.3 9.8 1.8 7.5 7.5 3.3 7.2 76.8 1.8 1.9 2.2 13.3 11.5 4.8 0.6 0.3 2.5 3.9 3.1 0.8 37.9 2.9 9.2 3.5 0.8 4.6 2.3 23.6 5.4 23.4 4.7 0.8 42.8 5.0 6.0 0.5 2.7 13.6 15.3 1.4 9.4 19.2 0.3 56.9 1.8 104.4 0.7 0.2 60.2 0.0 0.0 0.2 0.1 82.7 0.8 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.1 0.0 0.1 0.1 39.3 0.1 6.3 0.0 0.0 0.0 8.0 3.1 0.0 0.0 1.9 0.2 0.0 1.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.1 0.0 0.7 2.7 4.5 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.1 0.0 13.5 10.4 0.9 104.4 0.3 0.2 30.4 0.2 0.3 0.0 0.0 56.9 0.0 0.1 0.0 1.8 0.7 7.5 14.3 0.1 60.2 1.2 1.3 0.5 0.5 1.8 1.9 0.6 0.3 2.9 0.5 6.0 69.8 5.2 0.1 6.5 0.0 491.8 7.6 0.0 5.7 7.0 0.0 8.5 0.0 0.0 9.2 46.6 0.0 163.5 0.0 9.4 14.4 0.7 14.0 12.1 1111.0 0.0 0.0 465.9 196.7 2.3 0.6 68.0 15.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.3 685.6 31.5 4.7 0.7 4.1 15.3 1.3 0.0 0.1 CFD "ADN, DF, PFD" ENSG00000197766 "Complement factor D" P00746 19 859643-863630 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Fibroblasts: 1885.6;Leydig cells: 4659.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 125.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 125.0" "Group enriched" "Detected in some" 5 "ASC diff: 40.8;THP-1: 57.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 732000000 8000000000 "unprognostic (3.00e-2)" "unprognostic (6.09e-2)" "unprognostic (2.44e-1)" "unprognostic (1.22e-3)" "unprognostic (6.92e-2)" "unprognostic (5.28e-2)" "unprognostic (8.11e-3)" "unprognostic (2.48e-1)" "unprognostic (1.46e-2)" "unprognostic (8.10e-2)" "prognostic favorable (1.77e-4)" "unprognostic (9.53e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (1.23e-1)" "unprognostic (4.55e-2)" "unprognostic (1.92e-2)" "unprognostic (9.75e-2)" 161.3 4.6 0.0 16.4 0.0 5.6 96.7 0.0 1.7 44.2 35.2 0.2 42.2 10.9 8.9 89.8 54.1 15.6 59.0 102.0 0.0 0.0 1.9 2.3 34.0 6.2 0.0 0.0 13.7 6.0 1.7 0.1 20.2 0.1 102.0 4.3 3.4 22.7 15.1 40.5 35.8 16.5 97.3 0.1 3.7 19.7 33.6 0.0 0.8 52.6 55.6 9.0 83.7 130.3 0.6 5.6 125.0 25.8 0.1 1.0 10.4 0.7 1.9 0.0 0.3 40.8 6.4 2.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.6 0.2 0.0 0.0 1.1 2.9 0.0 1.8 0.6 0.6 0.3 1.0 6.4 0.0 0.0 0.0 0.1 0.0 0.7 2.3 0.1 0.0 0.9 0.0 9.2 0.1 0.7 2.9 0.2 0.0 0.9 0.0 0.1 0.3 0.3 0.8 0.2 0.0 0.1 1.2 57.8 0.0 0.0 0.9 0.4 0.1 1.7 0.7 0.0 0.0 3.4 0.0 125.0 18.2 58.8 0.7 20.1 1.0 0.6 0.5 0.9 5.6 0.2 0.7 0.8 43.2 0.1 25.8 0.5 0.3 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.9 35.0 13.4 57.2 697.8 3.1 53.7 12.7 21.4 23.9 17.4 2.0 31.1 10.0 6.7 18.8 25.9 9.3 0.0 0.0 35.1 1885.6 17.4 16.2 1.3 255.2 1.6 4.1 49.7 345.8 28.7 4659.7 242.8 609.0 5.4 7.5 1.2 1.9 32.5 266.2 2.5 6.3 0.0 277.1 11.8 20.4 643.3 28.7 9.2 18.5 172.1 CHIA "AMCase, CHIT2, TSA1902" ENSG00000134216 "Chitinase, acidic" Q9BZP6 1 111290862-111320566 "Enzymes, Predicted intracellular proteins" "Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 66.6" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 2: 22.2" "Cancer enhanced" "Detected in some" "lung cancer: 1.8;stomach cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "ASC diff: 6.0;HAP1: 3.1" "Low region specificity" "Detected in single" HPA059193 Approved "Intracellular and membrane" NA NA "HPA059193: AB_2683942" "unprognostic (8.00e-2)" "unprognostic (7.08e-2)" "unprognostic (2.02e-2)" "unprognostic (4.99e-2)" "unprognostic (7.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.5 0.8 0.3 0.1 0.1 0.1 0.0 0.5 1.0 13.2 0.2 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 66.6 0.5 0.1 0.1 0.5 0.1 0.1 0.1 0.1 1.6 0.7 0.0 0.1 0.6 0.6 0.3 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.2 0.5 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.7 0.2 0.2 0.0 1.6 0.6 0.0 0.0 0.6 0.0 0.7 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 22.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRDL1 "CHL, MGC1, NRLN1" ENSG00000101938 "Chordin like 1" Q9BU40 X 110673856-110795819 "Disease related genes, Predicted secreted proteins" "Differentiation, Neurogenesis, Osteogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Leydig cells: 38.0;Muller glia cells: 79.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 2.5" "Lineage enriched" "Detected in single" 24 "dendritic cells: 2.5" "Group enriched" "Detected in some" 9 "ASC diff: 93.3;ASC TERT1: 128.4;hTERT-RPE1: 58.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000226, HPA000250" Approved "Secreted in other tissues" NA NA 620000 "HPA000226: AB_1078522, HPA000250: AB_1078521" "unprognostic (5.13e-2)" "unprognostic (6.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.48e-3)" "unprognostic (1.99e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.42e-2)" "unprognostic (4.89e-2)" "unprognostic (5.54e-2)" "unprognostic (3.43e-2)" "unprognostic (3.56e-1)" "prognostic unfavorable (2.36e-4)" "unprognostic (4.75e-3)" "unprognostic (7.91e-2)" "unprognostic (5.01e-2)" "prognostic unfavorable (2.23e-4)" 53.1 2.2 7.2 11.5 12.3 0.2 40.8 3.7 8.4 22.0 25.7 1.4 40.9 3.1 57.3 29.5 18.7 18.1 14.2 22.0 5.4 1.7 4.5 0.7 27.6 7.5 1.7 6.8 7.5 3.6 51.4 2.8 15.2 2.2 46.1 11.1 15.2 8.5 73.9 3.2 6.9 7.7 31.0 3.4 6.5 8.6 5.8 2.4 0.8 14.9 23.7 3.4 16.3 11.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 93.3 128.4 0.0 1.2 0.5 3.1 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.2 0.0 58.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.6 9.8 1.2 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 7.2 12.3 3.7 8.4 5.4 1.7 1.7 6.8 2.2 2.4 0.0 2.4 0.0 0.0 4.2 1.0 1.2 0.0 2.7 3.4 1.8 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.1 15.1 0.2 1.1 0.0 0.2 0.0 0.0 2.5 0.0 0.2 38.0 2.4 8.5 0.0 0.0 79.4 0.0 0.0 8.5 2.2 2.5 0.0 2.8 0.1 9.1 3.9 0.1 0.0 0.0 0.1 CNR1 "CANN6, CB-R, CB1, CB1A, CB1K5, CNR" ENSG00000118432 "Cannabinoid receptor 1" P21554 6 88139864-88166359 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell type enriched" "Detected in some" 14 "Sertoli cells: 97.0" "Cancer enriched" "Detected in many" 13 "glioma: 12.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 6 "B-cells: 2.9" "Group enriched" "Detected in some" 7 "ASC diff: 40.3;HSkMC: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042256, HPA069945" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "HPA042256: AB_2677917, HPA069945: " "unprognostic (1.28e-1)" "unprognostic (7.04e-2)" "unprognostic (4.61e-2)" "unprognostic (4.08e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-3)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-2)" "unprognostic (2.74e-2)" "unprognostic (2.68e-1)" "unprognostic (1.70e-1)" "unprognostic (5.59e-3)" "unprognostic (2.68e-3)" "unprognostic (5.88e-2)" "unprognostic (7.00e-2)" 19.4 6.4 18.0 5.2 15.8 1.5 14.9 13.8 30.5 3.9 5.5 0.8 0.8 2.3 3.1 4.7 3.7 5.5 3.6 1.4 17.6 7.7 0.9 0.7 6.4 6.5 2.3 14.7 4.1 1.8 1.3 18.3 5.2 4.2 1.5 5.1 0.0 4.3 4.0 1.7 2.4 4.2 5.8 3.2 2.3 2.3 2.7 2.8 0.0 2.6 0.0 9.9 2.7 3.1 2.9 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 40.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.9 1.4 0.0 2.6 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 18.0 15.8 13.8 21.4 17.6 7.7 2.3 14.7 4.2 2.8 0.0 7.2 2.7 0.4 0.6 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 97.0 2.3 0.0 0.1 0.1 0.1 0.0 0.0 0.7 CRLF1 "CISS, CISS1, CLF, CLF-1" ENSG00000006016 "Cytokine receptor like factor 1" O75462 19 18572220-18607741 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Basal keratinocytes: 8.7;Ciliated cells: 6.7;Distal tubular cells: 5.0;Early spermatids: 6.3;Smooth muscle cells: 6.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 36.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "ASC diff: 151.1;Hep G2: 62.7" "Region enriched" "Detected in some" 7 "hippocampal formation: 23.3" "Low region specificity" "Detected in single" "HPA041493, HPA041793" Approved "Secreted in other tissues" NA NA "HPA041493: AB_10795637, HPA041793: AB_10804117" "unprognostic (1.97e-1)" "unprognostic (2.29e-1)" "unprognostic (2.34e-3)" "unprognostic (9.31e-3)" "unprognostic (1.58e-2)" "unprognostic (1.71e-2)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (4.69e-2)" "unprognostic (3.34e-3)" "unprognostic (4.95e-2)" "unprognostic (7.92e-2)" "prognostic unfavorable (3.96e-4)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.86e-2)" "unprognostic (5.27e-3)" 15.8 10.4 6.6 2.7 21.2 1.2 19.8 0.8 19.8 14.3 3.6 14.8 6.8 2.2 4.3 18.8 10.4 4.6 7.8 35.0 5.0 3.3 3.6 1.6 5.1 6.0 0.5 8.5 2.4 6.9 1.7 3.2 26.6 4.3 2.0 1.9 0.3 5.8 12.8 30.5 15.1 1.5 3.8 0.8 1.5 2.4 5.6 3.4 0.0 31.9 10.0 1.6 4.3 4.9 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 1.5 151.1 2.2 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.5 4.5 0.2 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.6 62.7 1.0 0.0 0.0 1.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 1.8 0.0 0.1 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.6 21.2 0.8 13.6 5.0 3.3 0.5 8.5 4.3 3.4 0.0 0.0 0.0 0.5 8.7 0.1 2.7 0.0 6.7 3.4 0.0 0.0 0.0 5.0 0.3 6.3 0.0 0.0 0.0 0.2 0.7 2.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.7 0.0 6.4 0.1 1.5 4.0 0.2 0.0 0.0 0.0 CRYAB "CRYA2, HSPB5" ENSG00000109846 "Crystallin alpha B" P02511 11 111908565-111923722 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Eye lens protein" "Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 743.1;skeletal muscle: 581.1" "Cell type enhanced" "Detected in many" 16 "Basal glandular cells: 1730.9;Cardiomyocytes: 6792.5;Proximal tubular cells: 5845.1" "Group enriched" "Detected in all" 6 "glioma: 426.4;renal cancer: 575.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 235.7;fHDF/TERT166: 76.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002053, CAB040560, HPA057100" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 12000 "Plasma membrane, Cytosol" "CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337" "unprognostic (1.06e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.90e-5)" "unprognostic (2.46e-2)" "unprognostic (3.02e-2)" "unprognostic (8.41e-3)" "unprognostic (9.29e-3)" "unprognostic (7.35e-2)" "unprognostic (8.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.68e-2)" "unprognostic (7.02e-2)" "unprognostic (3.68e-2)" "unprognostic (7.92e-2)" "unprognostic (8.83e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.70e-5)" 107.4 11.5 47.8 16.7 82.3 2.1 69.5 24.8 153.7 22.4 23.6 132.9 7.2 5.5 14.8 25.9 41.9 13.5 14.0 743.1 65.9 44.0 151.8 3.8 8.4 3.9 139.2 29.7 8.8 6.6 3.3 8.6 16.1 80.7 30.3 12.9 23.3 30.6 75.1 581.1 18.1 6.2 45.2 168.0 5.5 11.6 3.9 101.8 0.0 40.7 94.1 9.2 16.2 53.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.4 235.7 10.3 1.6 6.5 0.2 0.1 0.2 0.1 0.0 0.0 3.9 76.9 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 1.2 0.6 2.0 0.0 0.0 8.2 1.0 0.0 0.5 5.1 0.0 0.0 0.5 0.2 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.8 3.5 5.8 0.5 0.0 0.1 30.5 10.9 0.8 0.3 0.1 0.0 0.0 0.6 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 82.3 24.8 48.5 65.9 44.0 139.2 29.7 80.7 101.8 77.4 5.5 0.9 1730.9 155.3 11.4 6792.5 86.6 2.7 1.2 1270.1 17.7 2.9 573.6 165.7 20.3 23.3 0.0 0.0 10.0 5.8 309.0 1331.1 0.0 0.8 5.4 9.5 6.8 56.4 0.3 11.1 211.7 26.8 458.9 6.4 0.0 1097.1 19.7 0.0 176.4 5845.1 41.9 135.8 899.5 10.0 0.7 135.6 27.9 0.5 0.0 203.0 CTSK "CTSO, CTSO2, PKND, PYCD" ENSG00000143387 "Cathepsin K" P43235 1 150796208-150808323 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 104.1" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 61.1;Leydig cells: 110.1;Melanocytes: 92.8;Peritubular cells: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 6.7" "Lineage enriched" "Detected in many" 6 "monocytes: 6.7" "Group enriched" "Detected in some" 8 "ASC diff: 205.0;ASC TERT1: 75.1;BJ hTERT+: 165.6" "Low region specificity" "Detected in all" HPA050346 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA050346: AB_2681101" "unprognostic (1.48e-1)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (7.61e-3)" "unprognostic (5.08e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (6.60e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.49e-1)" "unprognostic (3.54e-2)" "prognostic unfavorable (7.12e-5)" "unprognostic (6.07e-3)" "unprognostic (2.98e-2)" "unprognostic (5.93e-3)" "unprognostic (6.41e-2)" 104.1 2.4 1.2 6.5 1.6 1.3 79.3 2.4 2.3 70.6 23.6 2.2 10.1 2.7 72.5 25.9 26.5 12.5 53.4 14.7 1.1 1.1 3.4 1.8 8.7 10.4 1.1 1.7 25.4 2.9 0.3 3.0 30.6 2.6 24.2 11.5 56.0 10.9 6.8 19.9 44.0 11.0 26.9 2.0 5.6 8.6 24.1 0.9 1.1 7.1 13.2 10.7 38.0 48.2 0.1 1.0 1.0 6.7 0.5 1.2 1.8 0.1 0.1 0.4 0.3 205.0 75.1 0.2 5.8 165.6 0.4 0.9 0.0 0.1 0.1 0.2 11.4 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.0 1.1 0.1 0.4 14.9 0.5 4.6 0.1 13.1 0.6 0.1 0.0 0.5 0.4 0.3 0.0 0.7 1.1 0.2 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.7 0.3 0.0 3.1 0.9 0.2 0.2 0.4 0.2 0.1 0.2 0.3 0.7 0.5 1.1 17.4 0.0 1.0 0.0 6.7 1.0 0.7 3.4 0.2 0.0 0.6 0.2 0.4 0.1 0.3 0.5 0.6 0.5 2.0 1.0 1.2 1.8 1.2 1.6 2.4 2.3 1.1 1.1 1.1 1.7 2.6 0.9 3.0 5.8 0.0 0.5 61.1 8.4 1.2 2.5 2.7 5.7 3.5 3.9 1.0 0.0 1.1 0.8 5.2 1.1 0.0 0.2 1.9 31.5 0.9 0.0 0.0 19.2 3.2 1.2 9.8 3.7 1.7 110.1 6.6 92.8 2.8 1.9 2.4 1.3 0.6 140.7 0.0 7.8 12.9 47.6 1.4 0.7 51.7 0.8 0.0 0.9 0.5 DPT ENSG00000143196 Dermatopontin Q07507 1 168695459-168729264 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.1" "Group enriched" "Detected in some" 4 "Fibroblasts: 155.7;Leydig cells: 214.6;Peritubular cells: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "ASC diff: 55.3;fHDF/TERT166: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA065548 Approved Vesicles "Secreted to extracellular matrix" NA NA 25000 Vesicles "HPA065548: AB_2685511" "unprognostic (1.49e-1)" "unprognostic (7.62e-2)" "unprognostic (5.66e-2)" "unprognostic (4.39e-2)" "unprognostic (4.64e-2)" "unprognostic (3.78e-3)" "unprognostic (4.09e-2)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" "unprognostic (1.03e-2)" "unprognostic (8.88e-2)" "unprognostic (2.16e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.12e-3)" "unprognostic (2.89e-2)" "unprognostic (1.09e-1)" "unprognostic (8.98e-3)" 128.1 6.1 0.8 22.6 0.8 0.0 99.3 0.8 2.4 51.0 81.7 0.9 19.8 2.4 20.4 38.8 33.1 23.0 52.3 48.8 0.8 0.3 2.4 6.0 9.6 7.7 0.8 0.8 12.8 13.4 0.0 0.9 7.8 0.9 24.0 9.4 1.8 14.4 10.2 13.0 8.6 23.1 76.1 0.8 1.0 23.6 8.7 0.8 2.3 16.3 55.7 22.8 48.7 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.3 0.2 0.0 0.0 2.4 2.7 2.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.8 2.4 0.8 0.3 0.8 0.8 0.9 0.8 3.0 1.7 0.0 0.1 28.3 0.0 5.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.6 0.4 0.0 0.0 0.2 0.3 155.7 0.2 0.0 0.0 0.6 0.0 0.0 12.9 0.0 0.7 214.6 0.0 37.1 0.0 0.0 0.0 0.3 0.0 116.3 0.0 0.0 0.0 15.0 0.3 0.3 28.0 0.3 0.0 0.0 0.5 ECM2 ENSG00000106823 "Extracellular matrix protein 2" O94769 9 92493554-92536655 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 43.8;Hepatocytes: 36.8;Leydig cells: 113.1;Peritubular cells: 65.4;Smooth muscle cells: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC diff: 11.4;ASC TERT1: 20.8;HSkMC: 21.9;hTCEpi: 24.9;hTERT-HME1: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035347 Approved "Secreted to extracellular matrix" NA NA 5500000 "HPA035347: AB_10669856" "unprognostic (2.48e-1)" "unprognostic (2.11e-1)" "unprognostic (2.27e-2)" "unprognostic (2.20e-2)" "unprognostic (5.35e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.50e-5)" "unprognostic (6.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.12e-3)" "unprognostic (2.39e-2)" "unprognostic (3.80e-2)" "unprognostic (6.63e-3)" 43.3 5.0 5.4 7.2 4.3 0.0 18.6 9.5 1.9 20.9 6.5 5.4 11.6 2.9 14.7 27.5 8.4 11.6 11.2 13.8 9.3 3.6 10.1 28.2 8.8 2.3 11.0 4.2 34.6 1.9 4.9 4.7 1.4 17.8 16.4 2.4 5.8 3.4 8.1 6.0 5.8 5.4 10.1 15.8 0.5 2.8 15.4 7.4 1.1 8.3 15.5 2.4 13.7 8.8 0.3 0.6 0.0 0.5 0.1 0.5 0.0 0.4 0.0 0.2 0.0 11.4 20.8 0.7 0.4 0.6 0.0 0.3 0.3 0.0 0.0 0.0 1.1 0.2 0.3 0.5 0.4 0.0 2.4 0.0 0.0 0.0 0.0 1.9 0.1 0.0 21.9 24.9 0.5 6.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.5 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.5 0.2 0.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 5.4 4.3 9.5 1.9 9.3 3.6 11.0 4.2 17.8 7.4 0.0 2.9 0.0 0.1 10.2 2.5 4.5 0.0 5.3 3.4 0.0 2.0 0.0 0.0 0.0 3.8 2.9 0.7 0.0 0.0 9.4 43.8 0.1 0.0 36.8 0.4 0.0 0.0 3.7 1.9 5.5 113.1 1.1 5.0 0.0 0.0 0.0 0.0 0.0 65.4 6.7 2.8 25.8 33.0 0.7 0.6 8.0 0.7 0.0 0.0 0.1 FABP4 "A-FABP, aP2" ENSG00000170323 "Fatty acid binding protein 4" P15090 8 81478419-81483263 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "adipose tissue: 492.7;breast: 545.8" "Cell type enriched" "Detected in many" 4 "Sertoli cells: 705.0" "Group enriched" "Detected in all" 7 "breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 145 "ASC diff: 282.1;RT4: 139.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002188, CAB024961" Enhanced NA NA 30000000 "CAB024961: , HPA002188: AB_1078822" "unprognostic (4.81e-2)" "unprognostic (2.30e-3)" "unprognostic (1.64e-3)" "unprognostic (2.63e-2)" "unprognostic (2.58e-1)" "unprognostic (8.70e-3)" "unprognostic (1.78e-3)" "unprognostic (1.67e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.56e-1)" "unprognostic (8.76e-2)" "unprognostic (1.13e-3)" "unprognostic (4.48e-2)" "unprognostic (2.26e-2)" "unprognostic (1.39e-1)" 492.7 3.5 0.3 16.1 0.3 0.1 545.8 0.2 0.2 0.9 42.2 0.0 1.8 0.2 0.6 2.9 4.8 1.0 7.6 15.6 0.3 0.3 1.2 0.4 9.3 4.7 0.3 0.0 0.7 1.3 2.2 0.3 15.9 0.3 7.7 2.9 0.1 7.6 1.7 13.0 5.5 4.5 3.3 0.3 0.7 2.2 6.1 0.0 0.7 7.4 7.3 0.1 15.4 60.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 282.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 139.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.2 0.3 0.3 0.3 0.0 0.3 0.0 32.8 75.0 1.5 0.4 12.8 0.2 16.2 0.0 40.2 48.9 0.0 0.0 0.3 0.0 0.1 0.9 172.1 0.0 0.0 4.6 0.6 7.6 0.4 25.6 0.0 120.8 0.0 0.0 12.9 57.0 0.6 1.4 13.8 15.1 1.0 0.0 0.7 0.1 0.0 1.1 0.0 1.7 705.0 59.7 0.0 0.1 12.2 0.6 0.0 0.0 61.1 FAM107A "DRR1, TU3A" ENSG00000168309 "Family with sequence similarity 107 member A" O95990 3 58564117-58627610 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Stress response" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.7" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 151.7;Ito cells: 84.7;Muller glia cells: 82.8" "Cancer enriched" "Detected in many" 6 "glioma: 110.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "ASC diff: 11.7;HUVEC TERT2: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055888 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA055888: AB_2682957" "unprognostic (1.20e-2)" "unprognostic (1.19e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.11e-1)" "unprognostic (7.80e-3)" "prognostic favorable (3.38e-4)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (5.73e-2)" "unprognostic (7.82e-3)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (1.33e-2)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (7.95e-3)" 22.4 4.6 119.4 4.7 86.5 1.3 8.4 32.4 149.7 17.0 7.6 68.6 1.7 3.6 9.4 25.1 13.9 39.6 8.4 15.8 91.5 52.0 12.4 3.5 18.1 2.4 66.6 44.3 4.3 11.1 4.1 12.0 13.8 33.5 16.3 8.4 10.7 17.5 19.4 7.5 3.5 5.8 19.8 77.5 12.0 5.8 2.5 87.2 1.2 9.9 1.4 4.8 6.5 10.2 0.3 0.3 1.3 0.9 0.7 0.6 0.1 0.0 0.0 0.5 0.0 11.7 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 1.9 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.3 0.4 0.5 0.3 0.4 0.6 0.2 0.3 0.2 0.2 0.3 0.2 0.3 0.6 0.7 0.9 0.3 0.3 0.1 119.4 86.5 32.4 80.7 91.5 52.0 66.6 44.3 33.5 87.2 6.0 8.5 0.0 39.0 1.9 4.2 23.8 5.1 4.0 5.7 36.6 49.1 0.0 8.3 0.9 13.1 151.7 0.0 0.0 0.2 0.0 9.4 6.0 1.1 0.8 0.0 3.2 3.5 84.7 1.3 25.6 30.5 1.9 5.0 0.0 0.0 82.8 0.5 0.0 11.0 1.9 41.9 6.5 14.4 0.7 0.2 2.4 0.0 0.0 0.0 0.9 FFAR3 "FFA3R, GPR41" ENSG00000185897 "Free fatty acid receptor 3" O14843 19 35358460-35360485 "G-protein coupled receptors, Predicted membrane proteins" "Immunity, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.5;blood: 5.6;lymphoid tissue: 6.1" "Cell type enhanced" "Detected in single" 19 "Macrophages: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 4.7;neutrophil: 5.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.6" "Group enriched" "Detected in some" 5 "ASC diff: 1.2;HHSteC: 3.9;HSkMC: 3.4;U-937: 1.5" HPA044681 Uncertain NA NA "HPA044681: AB_2679043" "unprognostic (1.15e-1)" "unprognostic (5.16e-3)" "unprognostic (1.45e-1)" "unprognostic (3.08e-2)" "unprognostic (1.03e-3)" "unprognostic (2.21e-2)" "unprognostic (4.46e-2)" "unprognostic (1.34e-1)" "unprognostic (1.92e-4)" "unprognostic (3.80e-1)" "unprognostic (1.11e-3)" "unprognostic (1.04e-3)" "unprognostic (2.18e-2)" "unprognostic (3.41e-1)" "unprognostic (3.22e-2)" 6.5 0.0 0.1 6.1 0.3 1.7 3.8 0.0 0.2 0.0 2.1 0.7 0.0 0.0 0.0 0.5 1.1 0.2 0.4 0.2 0.0 0.5 0.6 0.4 0.5 0.3 1.0 0.4 0.5 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.9 3.7 1.5 2.4 1.3 0.0 0.9 0.0 0.7 0.0 0.0 0.1 5.6 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.4 0.0 0.1 4.7 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FMO2 ENSG00000094963 "Flavin containing monooxygenase 2" Q99518 1 171185208-171211230 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.0;esophagus: 35.3;lung: 53.0" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 428.8;Club cells: 348.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 57 "ASC diff: 24.6;ASC TERT1: 11.2;HSkMC: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028261 Approved NA NA "HPA028261: AB_10601012" "unprognostic (1.85e-2)" "unprognostic (3.14e-2)" "unprognostic (7.44e-2)" "unprognostic (3.75e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-3)" "unprognostic (3.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.58e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (3.83e-2)" 40.0 11.8 1.2 1.7 4.4 0.0 22.5 1.5 0.6 7.6 5.0 0.6 2.9 0.3 1.9 3.5 35.3 6.7 2.0 17.4 1.8 1.2 9.4 1.8 53.0 5.7 3.9 1.2 6.1 2.1 1.8 7.0 0.0 2.4 6.0 0.7 8.3 14.0 1.3 7.6 1.7 1.5 2.5 1.9 0.4 2.4 3.3 1.3 0.4 5.8 6.8 5.5 5.0 10.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 29.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 4.4 1.5 0.6 1.8 1.2 3.9 1.2 2.4 1.3 428.8 20.8 0.0 5.3 0.3 0.2 6.9 0.0 62.9 348.1 1.8 0.0 0.0 0.0 0.0 2.7 5.3 0.0 0.0 0.0 0.0 0.6 3.0 3.5 0.0 0.0 0.0 0.0 4.3 0.0 2.3 0.9 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.4 0.2 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.0 1.1 FMO3 ENSG00000007933 "Flavin containing monooxygenase 3" P31513 1 171090877-171117819 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 170.2" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 378.8" "Cancer enriched" "Detected in many" 13 "liver cancer: 94.9" "Region enriched" "Detected in single" 5 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 25.4;ASC TERT1: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA013750 Enhanced NA NA "HPA013750: AB_1848968" "unprognostic (1.87e-2)" "unprognostic (6.30e-2)" "unprognostic (1.00e-1)" "unprognostic (6.81e-3)" "unprognostic (2.64e-1)" "unprognostic (1.31e-3)" "prognostic favorable (3.46e-4)" "prognostic favorable (5.60e-5)" "unprognostic (2.95e-1)" "unprognostic (9.34e-2)" "unprognostic (3.02e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (3.45e-1)" "unprognostic (7.27e-2)" 9.5 2.0 0.0 0.8 0.2 0.0 1.3 0.1 0.1 0.2 0.8 0.1 0.1 0.3 0.6 1.2 1.7 2.3 0.3 0.8 0.0 0.1 6.4 170.2 3.7 1.5 0.2 0.0 0.9 0.7 0.3 2.7 0.0 1.4 0.2 0.1 3.6 0.9 0.1 1.9 0.8 0.4 0.2 0.1 0.1 0.6 0.5 0.1 0.0 0.8 1.2 2.6 0.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 19.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 5.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.0 1.4 0.1 11.9 0.3 0.9 0.3 0.3 0.0 0.3 5.1 32.1 27.3 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 378.8 0.0 0.0 0.0 4.9 6.9 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 6.5 3.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 G0S2 ENSG00000123689 "G0/G1 switch 2" P27469 1 209675420-209676388 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 203.9;liver: 154.7" "Cell type enhanced" "Detected in many" 6 "Pancreatic endocrine cells: 558.7;Urothelial cells: 443.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 62 "neutrophil: 89.5" "Lineage enriched" "Detected in single" 197 "granulocytes: 89.5" "Group enriched" "Detected in some" 6 "ASC diff: 77.1;HBEC3-KT: 116.4;PC-3: 29.2;RPMI-8226: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-3)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (3.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.04e-3)" "unprognostic (3.03e-1)" "unprognostic (1.38e-1)" "unprognostic (2.32e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (7.57e-3)" "unprognostic (1.53e-2)" "unprognostic (4.78e-2)" "unprognostic (2.64e-1)" 130.1 23.3 1.1 18.5 1.1 203.9 85.2 2.0 0.9 2.0 11.3 1.4 29.9 1.6 6.1 9.3 2.0 4.0 13.5 43.7 1.1 0.8 22.2 154.7 51.6 6.4 1.8 0.0 18.4 5.3 0.5 1.2 2.6 1.3 8.7 1.1 3.1 49.2 73.5 97.9 3.0 3.5 3.8 1.5 6.3 7.1 5.3 1.1 0.0 3.1 14.3 6.1 12.6 13.1 0.0 0.0 89.5 0.1 0.0 0.4 0.0 0.0 0.6 0.0 0.0 77.1 2.7 0.0 0.1 0.2 0.3 0.3 3.0 2.4 0.0 0.6 0.5 0.4 0.0 0.0 116.4 0.7 0.1 0.2 0.0 0.2 0.1 6.3 0.0 0.0 8.0 0.2 5.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 29.2 0.0 0.0 37.1 0.2 0.0 0.1 0.2 2.6 0.0 0.6 0.0 0.0 8.9 11.7 0.0 0.8 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 1.1 1.1 2.0 0.9 1.1 0.8 1.8 0.0 1.3 1.1 8.9 93.3 5.6 295.9 206.4 0.2 325.1 12.7 41.5 55.7 10.4 0.0 1.1 253.7 40.5 12.3 26.3 16.9 0.0 123.5 3.9 183.7 312.4 36.0 83.1 183.0 0.0 28.2 14.1 41.0 7.4 106.2 375.5 310.4 50.5 30.7 19.9 558.7 40.3 67.1 223.2 0.0 32.3 88.6 21.4 1.1 141.0 3.5 4.8 37.5 443.6 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174649-16231992 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 66.7;brain: 52.3" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 19.5;Endothelial cells: 15.2;Ito cells: 39.9;Muller glia cells: 48.3" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 44.9;ASC TERT1: 44.3;HSkMC: 33.7" "Group enriched" "Detected in many" 4 "cerebellum: 10.7;pons and medulla: 6.7" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 25000 "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 66.7 5.3 7.6 2.6 17.4 1.1 22.8 2.3 31.5 3.9 8.6 28.1 1.1 2.8 3.5 3.3 11.4 5.3 5.2 7.3 14.8 6.6 8.3 2.8 3.1 3.4 38.9 8.4 8.4 3.2 1.6 1.0 35.5 24.8 4.9 3.8 1.3 8.0 4.1 17.3 11.6 5.3 10.5 52.3 12.8 4.6 8.1 19.9 0.0 6.3 1.6 1.5 16.6 23.5 0.6 0.9 0.9 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 44.9 44.3 0.0 1.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 33.7 0.0 0.4 0.5 0.3 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.2 7.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.0 0.6 0.4 0.2 0.9 0.3 0.3 0.9 0.3 0.3 7.6 17.4 2.3 13.6 14.8 6.6 38.9 8.4 24.8 19.9 0.0 1.7 0.0 0.5 0.5 0.8 1.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.5 15.2 0.0 0.0 0.0 0.0 2.9 1.2 1.1 0.2 0.1 0.0 0.0 39.9 0.6 10.6 1.7 0.2 0.0 0.0 0.0 48.3 0.2 0.0 0.7 0.0 3.1 0.0 1.2 10.2 0.5 0.6 0.0 0.0 0.0 0.1 GGT5 "GGT-REL, GGTLA1" ENSG00000099998 "Gamma-glutamyltransferase 5" P36269 22 24219654-24245142 "Enzymes, Predicted intracellular proteins" "Glutathione biosynthesis, Leukotriene biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Ito cells: 44.2;Sertoli cells: 181.1;Smooth muscle cells: 82.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.5" "Group enriched" "Detected in some" 4 "ASC diff: 39.5;ASC TERT1: 30.1;HHSteC: 56.4;HSkMC: 65.0;TIME: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008121, CAB032489" Uncertain Approved "Nucleoli fibrillar center" "Intracellular and membrane" NA NA 18000000 "Nucleoli fibrillar center" "CAB032489: AB_2111010, HPA008121: AB_1078965" "unprognostic (8.14e-2)" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (9.94e-2)" "unprognostic (8.13e-2)" "unprognostic (8.21e-2)" "unprognostic (2.33e-2)" "unprognostic (2.90e-1)" "unprognostic (1.81e-2)" "unprognostic (1.07e-1)" "unprognostic (8.37e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (6.36e-5)" "prognostic unfavorable (4.06e-4)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.79e-1)" "unprognostic (8.33e-2)" 20.2 14.8 2.0 5.2 3.5 0.0 13.2 0.5 4.2 10.7 4.0 5.7 7.9 3.6 2.1 10.2 12.1 14.0 2.4 3.4 13.1 13.7 5.1 12.4 4.7 3.9 5.0 2.2 6.0 3.2 6.5 3.4 5.4 6.8 2.5 5.3 7.2 10.1 2.7 4.8 5.6 1.2 17.2 5.2 6.3 9.3 0.1 0.4 7.5 0.9 0.8 0.1 0.4 0.0 0.3 0.0 0.0 39.5 30.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.1 5.2 56.4 0.6 1.4 65.0 0.0 0.7 0.7 0.0 10.6 0.1 0.1 0.1 10.1 0.1 0.0 4.9 0.6 0.1 0.0 0.0 0.9 0.1 1.1 0.0 0.0 1.4 0.0 1.7 0.0 5.6 0.2 0.3 25.2 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.9 1.1 0.0 4.0 0.9 7.5 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.9 0.8 0.0 0.1 0.0 0.4 3.0 16.5 0.5 3.1 6.3 0.0 4.8 0.0 2.7 11.4 0.0 0.0 0.2 0.0 0.1 0.5 37.5 0.0 0.0 0.2 0.1 8.7 1.3 1.1 0.0 1.6 0.0 0.0 44.2 1.2 2.6 33.6 2.9 3.3 5.4 0.0 0.2 0.3 0.0 22.3 0.0 0.4 181.1 82.1 0.3 0.4 3.9 0.2 0.0 0.0 0.9 ISM1 "bA149I18.1, C20orf82" ENSG00000101230 "Isthmin 1" B1AKI9 20 13221771-13300651 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 33.8" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 4.0;Fibroblasts: 8.1;Proximal tubular cells: 3.1;Suprabasal keratinocytes: 2.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.0;naive CD4 T-cell: 3.3" "Lineage enriched" "Detected in single" 40 "T-cells: 4.0" "Group enriched" "Detected in some" 5 "ASC diff: 36.3;Hep G2: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.13e-2)" "unprognostic (3.55e-1)" "unprognostic (4.43e-3)" "unprognostic (5.27e-3)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.06e-1)" "unprognostic (4.48e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.32e-6)" "unprognostic (2.58e-2)" "unprognostic (2.10e-1)" "unprognostic (6.83e-2)" "unprognostic (1.81e-2)" 7.8 2.4 0.8 0.5 1.1 0.0 17.0 0.7 1.5 2.4 2.1 0.8 2.0 0.3 1.8 2.3 4.5 2.3 4.4 2.2 1.0 1.7 2.4 4.5 3.2 1.0 0.7 0.9 1.1 5.7 0.1 1.0 12.7 1.3 1.9 0.2 0.8 8.9 0.7 2.3 9.2 1.1 1.7 0.6 4.8 1.9 1.2 0.8 1.4 33.8 5.5 1.1 3.8 6.1 0.0 0.0 0.0 0.0 0.0 4.0 1.5 0.0 0.3 0.2 0.5 36.3 5.1 0.2 0.3 3.0 0.0 0.0 2.0 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 13.9 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.2 0.0 0.3 0.3 0.0 0.2 1.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 1.0 0.1 0.7 0.0 0.0 0.0 2.1 0.3 0.1 0.2 0.0 3.4 0.6 0.0 1.6 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 0.0 0.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 1.5 0.8 1.1 0.7 1.5 1.0 1.7 0.7 0.9 1.3 0.8 0.0 0.3 0.0 0.5 4.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 2.3 0.0 0.0 0.0 0.2 8.1 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.8 0.0 0.2 2.5 0.6 0.5 0.0 0.1 JAK2 JTK10 ENSG00000096968 "Janus kinase 2" O60674 9 4984390-5128183 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 40.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 40.8" "Group enriched" "Detected in many" 5 "ASC diff: 19.4;HDLM-2: 27.4;HEL: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013089, HPA040820, HPA043870" Approved Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" No No Nucleoplasm "Plasma membrane, Focal adhesion sites" "CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708" "unprognostic (2.24e-3)" "unprognostic (2.76e-2)" "unprognostic (1.50e-2)" "unprognostic (7.67e-2)" "unprognostic (5.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" "unprognostic (3.85e-1)" "unprognostic (4.53e-2)" "unprognostic (3.43e-2)" "unprognostic (1.96e-1)" "unprognostic (7.37e-3)" 19.8 8.8 11.5 19.0 10.5 19.0 17.7 14.7 14.4 17.8 10.6 7.0 10.3 7.2 14.8 13.6 12.4 13.4 14.6 27.6 10.3 6.7 7.7 5.6 16.1 19.4 7.0 10.5 15.9 6.7 10.1 7.5 12.0 10.0 12.0 7.4 9.4 7.2 7.4 14.4 19.0 12.3 10.4 11.7 21.5 14.1 10.1 9.0 13.6 8.6 6.5 13.5 13.9 15.6 2.1 9.6 40.8 7.5 3.4 2.1 2.5 2.5 1.5 1.5 2.5 19.4 5.0 0.4 3.5 3.0 2.7 1.8 0.1 0.8 0.1 0.8 2.1 2.2 0.9 1.6 2.1 2.0 27.4 0.5 56.1 3.0 0.7 4.0 3.8 2.9 4.1 0.9 1.1 1.8 3.3 2.5 2.0 4.0 6.5 4.8 0.9 0.9 5.4 1.3 1.3 1.7 1.9 2.8 0.8 2.0 1.3 1.7 0.9 1.0 1.5 1.1 1.6 0.8 6.7 5.1 4.1 1.4 4.2 2.4 1.2 2.3 0.5 5.3 1.9 2.0 40.8 7.5 13.4 2.1 7.3 1.7 2.1 1.6 1.2 9.6 1.9 0.9 1.1 7.1 3.4 5.8 3.6 1.6 2.5 11.5 10.5 14.7 14.4 10.3 6.7 7.0 10.5 10.0 9.0 14.9 6.4 6.9 2.8 8.7 7.4 22.0 0.0 5.3 7.9 7.0 7.9 1.8 1.7 3.0 7.4 8.7 3.9 23.3 3.4 0.8 7.0 1.7 13.9 1.6 11.9 7.9 2.9 4.9 36.0 5.3 21.9 27.7 5.0 16.2 4.2 12.2 5.4 14.4 31.5 2.5 11.1 0.0 5.0 14.9 5.7 7.3 2.9 5.0 3.3 4.1 KLB ENSG00000134962 "Klotho beta" Q86Z14 4 39406853-39451536 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adipose tissue: 17.3;liver: 49.2;pancreas: 21.4" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 12.1;Hepatocytes: 28.7;Intestinal endocrine cells: 16.7;Spermatocytes: 11.1" "Cancer enriched" "Detected in some" 16 "liver cancer: 11.6" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 23 "ASC diff: 6.5;Hep G2: 23.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021136 Uncertain NA NA 290000 "HPA021136: AB_1852616" "unprognostic (1.03e-2)" "unprognostic (1.61e-2)" "unprognostic (4.67e-2)" "unprognostic (2.69e-1)" "unprognostic (4.30e-2)" "unprognostic (7.02e-3)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (6.99e-3)" "unprognostic (4.51e-3)" "unprognostic (3.02e-3)" "unprognostic (8.90e-3)" "unprognostic (1.73e-1)" "unprognostic (5.03e-2)" "unprognostic (4.53e-2)" "unprognostic (3.87e-2)" "unprognostic (3.09e-2)" 17.3 0.0 0.2 1.9 1.0 0.2 3.9 0.4 0.2 0.0 1.6 0.0 0.0 0.2 0.1 0.5 0.3 0.1 1.3 0.5 1.0 0.2 0.1 49.2 1.4 0.5 0.1 0.0 0.2 21.4 0.2 0.2 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.4 0.5 0.6 0.3 0.0 0.0 1.5 2.5 0.2 0.0 0.1 0.4 0.0 0.3 0.2 0.5 2.5 2.3 0.7 0.4 0.4 0.2 0.0 0.2 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 23.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.7 0.2 0.3 0.4 0.2 0.4 0.2 0.2 0.1 0.5 0.2 0.4 2.3 0.4 0.5 2.5 0.1 0.2 0.2 1.0 0.4 0.2 1.0 0.2 0.1 0.0 0.4 0.2 3.0 12.1 0.0 0.9 0.5 2.1 0.9 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.9 5.9 0.3 1.4 0.0 3.7 1.1 0.4 1.0 0.0 28.7 0.2 1.6 16.7 0.0 0.3 1.1 1.4 0.2 1.7 0.0 6.7 0.3 1.4 3.5 0.7 0.8 1.6 0.0 0.0 11.1 0.7 0.6 1.1 0.0 0.6 0.7 KRTAP20-2 KAP20.2 ENSG00000184032 "Keratin associated protein 20-2" Q3LI61 21 30635236-30635619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 12 "skin 1: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "ASC diff: 3.3;U-2 OS: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 LBP BPIFD2 ENSG00000129988 "Lipopolysaccharide binding protein" P18428 20 38346356-38377023 "Plasma proteins, Predicted secreted proteins, Transporters" "Immunity, Innate immunity, Lipid transport, Transport" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "liver: 429.7" "Cell type enriched" "Detected in some" 15 "Hepatocytes: 356.7" "Cancer enriched" "Detected in many" 20 "liver cancer: 356.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "ASC diff: 12.4;HSkMC: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001508, CAB025905" Approved "Secreted to blood" NA NA 25000000000 910000000 "CAB025905: , HPA001508: AB_1079241" "unprognostic (4.20e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (4.54e-2)" "unprognostic (2.47e-1)" "unprognostic (3.80e-2)" "unprognostic (2.53e-2)" "unprognostic (5.50e-2)" "unprognostic (2.48e-3)" "unprognostic (6.15e-2)" "unprognostic (2.12e-1)" "unprognostic (7.93e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (3.62e-12)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" 12.8 0.0 0.1 4.7 0.1 0.0 0.7 0.1 0.1 0.6 0.4 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.1 0.4 0.1 0.0 3.1 429.7 0.1 0.5 0.1 0.1 0.2 0.2 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 4.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 1.4 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.1 0.0 12.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.7 0.0 0.0 0.0 0.0 0.1 6.6 0.3 0.6 0.0 0.0 23.3 9.1 0.1 0.0 0.0 0.0 356.7 0.3 0.0 0.0 11.1 8.6 0.0 0.6 0.0 0.0 1.0 0.0 0.0 8.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 LGALS12 GRIP1 ENSG00000133317 "Galectin 12" Q96DT0 11 63506084-63516774 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 45.1;blood: 90.2;breast: 28.6" "Cell type enriched" "Detected in some" 8 "granulocytes: 18.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enriched" "Detected in some" 19 "eosinophil: 90.2" "Lineage enriched" "Detected in many" 19 "granulocytes: 90.2" "Group enriched" "Detected in some" 14 "ASC diff: 11.8;HL-60: 20.4;NB-4: 40.2;U-937: 43.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA021124 Approved Cytosol NA NA Cytosol "HPA021124: " "unprognostic (3.89e-2)" "unprognostic (4.40e-2)" "unprognostic (5.17e-2)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.31e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-3)" "unprognostic (4.69e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (4.60e-7)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (6.22e-2)" "unprognostic (8.60e-2)" 45.1 0.5 0.1 5.8 1.1 10.1 28.6 0.0 0.1 0.1 10.6 0.0 0.0 0.3 0.2 1.1 0.1 0.7 7.7 2.2 0.1 0.1 0.4 0.2 1.4 5.3 0.1 0.0 0.5 0.5 0.0 0.1 0.1 0.2 0.7 0.4 0.1 5.9 1.6 1.6 0.6 1.4 0.6 0.2 0.8 0.4 0.1 0.0 0.1 0.5 2.4 0.2 0.9 0.2 0.0 1.2 90.2 4.7 0.0 0.0 2.8 0.0 0.0 0.0 0.0 11.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 20.4 1.3 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 43.1 0.0 1.8 4.7 90.2 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 2.8 0.1 1.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LMO3 "DAT1, RBTNL2, Rhom-3" ENSG00000048540 "LIM domain only 3" Q8TAP4 12 16548373-16610594 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.5" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 160.8;Alveolar cells type 2: 154.4;Ciliated cells: 111.1;Club cells: 110.3;Collecting duct cells: 50.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "ASC diff: 70.7;LHCN-M2: 31.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-2)" "unprognostic (2.84e-1)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.10e-7)" "unprognostic (3.62e-2)" "unprognostic (5.44e-2)" "unprognostic (6.56e-3)" "unprognostic (4.91e-2)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (1.39e-5)" "unprognostic (4.41e-2)" "unprognostic (1.61e-1)" "unprognostic (2.13e-3)" "unprognostic (4.83e-2)" 15.9 8.3 38.1 3.1 43.9 1.2 8.2 5.2 87.5 13.1 22.6 5.8 6.4 2.0 8.7 3.4 3.1 2.1 6.3 3.6 20.8 9.4 4.0 1.3 30.0 1.3 14.5 27.6 9.6 29.6 2.1 7.9 2.1 12.9 11.2 9.9 0.9 4.1 25.7 1.2 1.3 4.3 16.9 4.2 1.4 2.6 1.7 8.6 0.3 30.4 0.0 1.2 15.9 6.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.1 43.9 5.2 42.5 20.8 9.4 14.5 27.6 12.9 8.6 160.8 154.4 0.0 0.2 0.2 0.2 0.8 0.0 111.1 110.3 50.6 17.7 0.2 3.3 0.0 2.6 0.0 0.0 0.0 3.0 0.0 3.1 0.2 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 3.3 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.5 0.0 1.9 1.7 0.7 0.1 0.2 0.0 0.0 0.1 LRRC32 "D11S833E, GARP" ENSG00000137507 "Leucine rich repeat containing 32" Q14392 11 76657524-76670747 "Predicted intracellular proteins, Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 91.0;Extravillous trophoblasts: 149.6;Fibroblasts: 48.9;Ito cells: 70.6;Sertoli cells: 38.8;Smooth muscle cells: 74.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "neutrophil: 1.0;T-reg: 3.1" "Group enriched" "Detected in many" 7 "granulocytes: 1.0;T-cells: 3.1" "Group enriched" "Detected in some" 6 "ASC diff: 42.0;ASC TERT1: 25.9;HSkMC: 16.1;HUVEC TERT2: 18.2;U-2197: 38.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA055775, HPA058434" Enhanced Nucleoplasm "Intracellular and membrane" NA NA 19000 Nucleoplasm "HPA055775: AB_2732600, HPA058434: AB_2732622" "unprognostic (3.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (4.19e-3)" "unprognostic (1.16e-1)" "unprognostic (8.84e-2)" "unprognostic (1.39e-2)" "unprognostic (2.24e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.58e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (3.93e-5)" "unprognostic (7.99e-3)" "unprognostic (1.15e-2)" "unprognostic (5.22e-3)" "prognostic unfavorable (2.64e-4)" 50.5 16.5 5.4 8.0 11.3 1.9 35.1 4.6 9.1 19.8 12.4 4.4 3.5 7.0 15.2 10.4 11.1 10.8 22.6 18.0 7.6 3.5 19.5 8.5 51.8 4.7 10.2 4.3 19.9 8.7 7.9 7.0 40.5 10.1 12.6 5.1 16.6 5.2 9.4 29.0 9.9 7.7 13.0 5.7 21.2 8.1 8.6 8.7 0.6 16.6 9.7 2.1 19.8 25.1 0.2 0.0 1.0 0.0 0.0 3.1 9.6 0.0 0.0 0.4 0.0 42.0 25.9 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.8 0.0 0.0 16.1 0.0 1.4 0.0 0.3 18.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 4.8 2.7 0.3 38.6 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.1 9.6 5.4 11.3 4.6 9.1 7.6 3.5 10.2 4.3 10.1 8.7 0.0 7.0 3.4 0.2 12.9 0.0 3.4 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.1 1.3 91.0 0.0 0.0 0.0 149.6 48.9 1.2 2.3 0.8 3.3 0.0 0.0 70.6 4.4 1.1 8.3 5.2 16.9 0.0 0.2 0.4 0.0 2.9 8.5 0.1 0.0 38.8 74.8 0.5 2.7 10.9 7.0 1.3 0.0 1.1 MEDAG "AWMS3, C13orf33, FLJ14834, MEDA-4" ENSG00000102802 "Mesenteric estrogen dependent adipogenesis" Q5VYS4 13 30906191-30925572 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 63.0" "Cell type enhanced" "Detected in some" 16 "Fibroblasts: 43.8;Leydig cells: 17.5;Smooth muscle cells: 18.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.6" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "ASC diff: 77.9;ASC TERT1: 21.9;U-2197: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.44e-2)" "unprognostic (3.42e-2)" "unprognostic (6.06e-3)" "unprognostic (8.80e-2)" "unprognostic (1.07e-1)" "unprognostic (3.71e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (3.29e-5)" "unprognostic (8.69e-3)" "unprognostic (2.48e-1)" "unprognostic (5.41e-3)" "unprognostic (7.52e-2)" 63.0 1.9 0.1 7.4 0.3 0.2 43.8 0.1 0.4 9.0 10.0 0.3 7.5 1.2 10.2 24.8 13.3 14.5 7.2 18.6 0.4 0.4 2.0 0.4 5.3 7.3 0.4 0.5 17.9 6.8 0.5 2.2 6.4 2.6 3.6 3.2 4.6 6.0 1.7 27.1 8.0 3.5 10.8 2.4 0.4 5.2 9.5 0.1 0.0 15.3 12.7 3.6 21.5 10.5 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 77.9 21.9 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 9.2 0.0 11.1 0.0 0.0 10.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 9.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 11.1 0.0 0.0 42.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.4 0.4 0.4 0.5 2.6 0.1 0.0 0.3 0.0 0.0 10.2 0.0 4.2 0.0 1.4 2.3 0.0 0.0 0.1 0.0 1.2 1.0 6.7 0.0 0.0 0.0 0.4 43.8 1.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 1.3 17.5 0.6 10.1 0.0 0.0 0.0 0.3 0.0 9.2 0.1 0.0 0.0 18.8 0.0 0.0 9.2 0.2 0.0 0.0 0.5 MRO "B29, C18orf3, FLJ30140" ENSG00000134042 Maestro Q9BYG7 18 50795120-50825402 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 17.5;kidney: 24.3;testis: 30.9" "Group enriched" "Detected in some" 4 "Ito cells: 55.9;Kupffer cells: 14.2" "Cancer enriched" "Detected in some" 7 "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 4.6;ASC TERT1: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022011 Approved NA NA "HPA022011: AB_2670880" "unprognostic (9.21e-5)" "unprognostic (5.22e-2)" "unprognostic (7.87e-3)" "unprognostic (1.45e-2)" "unprognostic (2.47e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.32e-1)" "unprognostic (4.71e-1)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (3.99e-3)" "unprognostic (6.06e-4)" 2.7 3.2 12.2 0.9 13.9 0.6 1.0 4.5 17.5 0.7 0.7 13.9 1.0 8.3 0.5 4.1 0.9 0.7 1.7 4.4 15.4 5.9 24.3 7.7 0.7 0.7 9.1 10.3 3.8 2.2 3.8 1.3 1.2 11.1 0.7 0.6 1.6 0.7 2.7 2.4 0.5 5.3 0.7 10.7 2.5 1.8 30.9 12.4 0.0 6.6 0.0 0.5 0.8 0.6 0.8 0.9 2.1 1.2 0.5 0.4 0.0 0.0 0.0 0.1 0.3 4.6 14.0 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.4 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.6 0.1 0.4 0.2 0.4 0.1 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.2 1.0 0.5 0.2 0.3 0.9 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.4 2.1 0.5 1.2 0.9 0.2 0.0 12.2 13.9 4.5 11.2 15.4 5.9 9.1 10.3 11.1 12.4 0.0 0.0 2.2 0.1 0.0 0.0 5.3 2.5 0.0 0.0 0.0 2.0 0.0 5.0 0.0 0.5 0.0 0.0 0.0 0.9 0.6 0.2 0.1 0.0 4.3 8.7 0.0 0.0 55.9 14.2 2.2 1.1 0.1 0.0 0.0 0.0 3.9 0.1 0.0 0.7 7.5 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 OMD "osteoadherin, SLRR2C" ENSG00000127083 Osteomodulin Q99983 9 92414245-92424461 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Fibroblasts: 27.7;Leydig cells: 90.6;Peritubular cells: 103.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "ASC diff: 12.6;ASC TERT1: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069948 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Secreted in other tissues" NA NA 14000000 "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA069948: AB_2732144" "unprognostic (1.18e-1)" "unprognostic (2.33e-3)" "unprognostic (5.04e-2)" "unprognostic (2.26e-1)" "unprognostic (9.42e-2)" "unprognostic (1.87e-2)" "unprognostic (4.31e-3)" "unprognostic (6.42e-2)" "unprognostic (4.53e-1)" "unprognostic (3.89e-2)" "unprognostic (1.18e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-3)" "unprognostic (5.81e-3)" "unprognostic (6.35e-2)" "unprognostic (2.84e-3)" "unprognostic (2.08e-3)" 14.0 7.9 2.2 1.2 4.3 0.0 14.6 3.7 3.4 20.3 8.3 1.0 8.0 0.8 8.2 19.3 14.0 8.7 8.9 20.2 2.8 1.7 2.9 0.8 12.2 0.8 7.0 5.4 15.3 1.8 1.5 4.2 11.5 6.0 13.6 2.2 14.2 2.3 4.2 2.8 3.5 3.7 13.9 19.3 0.7 5.0 12.8 1.3 0.2 9.2 14.5 3.2 22.1 7.6 0.3 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 12.6 11.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 2.2 4.3 3.7 3.4 2.8 1.7 7.0 5.4 6.0 1.3 0.0 0.0 0.0 0.2 2.4 0.6 1.1 0.0 0.0 1.2 1.8 0.0 0.1 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.1 27.7 0.1 0.0 0.0 0.3 0.0 0.0 16.5 0.3 1.3 90.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 103.6 0.0 1.3 0.0 3.4 0.2 0.1 2.4 0.0 0.0 0.0 0.1 OR2L13 OR2L14 ENSG00000196071 "Olfactory receptor family 2 subfamily L member 13" Q8N349 1 248095184-248101103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.2;brain: 7.3" "Cell type enhanced" "Detected in single" 20 "Early spermatids: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 13 "B-cells: 1.0;granulocytes: 3.2;T-cells: 1.5" "Group enriched" "Detected in some" 9 "ASC diff: 1.1;GAMG: 2.5;WM-115: 2.9" NA NA "unprognostic (1.39e-2)" "unprognostic (1.53e-1)" "unprognostic (9.89e-2)" "unprognostic (3.66e-1)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.14e-1)" 0.0 2.0 2.1 0.0 2.4 0.2 0.6 0.7 7.3 0.1 0.1 0.0 0.0 1.2 0.0 1.0 0.0 0.0 2.5 3.2 0.0 0.0 0.0 0.2 3.5 0.2 0.0 0.0 0.2 0.1 1.8 0.1 0.0 0.6 0.0 0.0 0.0 0.1 4.5 1.1 0.0 1.2 0.9 0.1 0.1 0.0 1.0 0.1 3.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 3.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.6 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "ASC diff: 18.9;ASC TERT1: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.5 0.3 0.1 18.9 7.5 0.0 0.8 0.2 0.1 0.4 0.0 0.0 0.9 0.4 0.3 1.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.6 0.8 0.3 0.5 0.7 0.1 0.0 0.3 0.9 0.7 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.3 1.6 0.0 1.0 0.7 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.8 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 0.0 0.6 0.0 0.6 0.1 10.6 1.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.3 1.1 0.0 0.1 9.5 0.0 1.8 0.3 0.0 3.4 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.8 0.0 1.1 6.5 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 PDE1A ENSG00000115252 "Phosphodiesterase 1A" P54750 2 182140036-182523192 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.0;kidney: 37.1" "Group enriched" "Detected in many" 6 "Distal tubular cells: 157.5;Early spermatids: 314.8;Late spermatids: 455.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "ASC diff: 22.8;HHSteC: 13.5;HSkMC: 28.9" "Group enriched" "Detected in many" 6 "amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8" "Low region specificity" "Detected in all" HPA022151 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022151: AB_1855118" "unprognostic (3.63e-1)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (8.61e-2)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (3.84e-1)" "unprognostic (3.82e-1)" "unprognostic (1.02e-1)" "unprognostic (5.38e-2)" "unprognostic (2.78e-1)" "unprognostic (2.86e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-3)" "unprognostic (5.96e-2)" "unprognostic (1.37e-1)" "unprognostic (1.40e-3)" 7.6 3.9 13.8 3.6 11.5 0.5 4.1 66.0 25.3 11.5 8.8 6.2 1.7 2.6 7.3 6.7 4.7 7.4 18.2 11.8 12.6 4.1 37.1 3.2 3.1 1.8 7.1 15.7 9.2 2.0 1.3 2.3 1.3 6.9 3.8 5.6 3.0 1.8 4.8 2.4 2.1 4.6 11.8 10.1 2.6 4.6 24.6 9.0 0.0 35.1 2.6 1.1 8.3 9.0 0.0 1.4 0.8 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.0 22.8 1.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 13.5 0.0 0.0 28.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 3.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.8 11.5 66.0 25.3 12.6 4.1 7.1 15.7 6.9 9.0 0.0 1.6 0.0 2.2 1.1 12.6 3.6 0.0 0.0 2.3 26.2 0.0 0.1 157.5 0.3 314.8 5.8 0.0 0.0 0.3 0.0 1.9 2.0 0.0 0.0 0.1 0.0 0.0 8.0 0.0 455.7 13.8 0.2 0.0 0.0 0.6 0.2 0.2 0.0 7.8 1.4 1.1 51.8 47.4 4.4 3.9 1.1 0.0 0.0 0.0 0.7 PDGFD "IEGF, MSTP036, SCDGF-B" ENSG00000170962 "Platelet derived growth factor D" Q9GZP0 11 103907186-104164379 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 48.2" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 30.6;Ductal cells: 17.7;Horizontal cells: 25.4;T-cells: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 7.1;gdT-cell: 13.6;memory CD8 T-cell: 5.8;naive CD8 T-cell: 5.1;NK-cell: 12.6" "Group enriched" "Detected in many" 27 "granulocytes: 7.1;NK-cells: 12.6;T-cells: 13.6" "Group enriched" "Detected in some" 6 "ASC diff: 56.8;HHSteC: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046183, HPA066271" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 24000 "Golgi apparatus, Vesicles" "HPA046183: AB_2679573, HPA066271: AB_2685645" "unprognostic (2.21e-1)" "unprognostic (9.35e-2)" "unprognostic (5.60e-2)" "unprognostic (1.72e-1)" "unprognostic (5.81e-2)" "unprognostic (8.83e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (2.26e-1)" "unprognostic (7.01e-3)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.19e-1)" "unprognostic (6.72e-2)" "unprognostic (3.57e-3)" 26.1 48.2 1.1 10.1 1.5 0.1 21.2 0.6 1.8 13.8 5.6 1.1 15.0 1.5 9.8 10.2 2.7 5.3 20.6 13.9 0.9 1.9 4.3 1.8 2.3 3.5 0.8 1.6 33.4 32.8 5.0 14.4 8.5 6.4 8.5 4.0 16.7 6.0 16.2 9.8 5.1 2.2 4.0 2.1 2.3 8.6 5.4 0.0 1.1 11.5 4.4 4.6 13.5 10.0 0.4 0.0 7.1 0.0 12.6 13.6 2.9 0.0 3.0 1.6 0.0 56.8 1.7 0.0 0.3 0.3 0.2 0.3 0.0 0.5 2.8 0.5 2.8 2.0 0.1 0.0 0.1 0.1 0.0 1.2 0.0 0.6 0.1 17.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.8 0.0 2.6 0.0 0.0 3.8 0.0 5.4 1.2 0.7 0.0 0.7 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 7.1 13.6 0.0 1.1 0.4 1.5 5.8 0.0 0.0 0.1 5.1 0.2 12.6 0.0 0.0 0.1 2.9 1.1 1.5 0.6 1.8 0.9 1.9 0.8 1.6 6.4 0.0 0.0 0.0 1.7 5.5 2.7 1.0 3.1 30.6 0.0 1.2 5.2 0.0 0.1 0.0 17.7 7.6 7.1 0.0 0.0 3.8 0.1 7.6 1.2 0.0 0.0 0.3 25.4 1.7 3.7 0.3 9.4 0.3 0.0 0.0 1.0 0.7 1.1 3.7 0.0 2.1 0.1 0.3 6.5 2.1 0.3 1.7 1.8 0.0 18.5 0.6 3.1 PDGFRB "CD140b, JTK12, PDGFR, PDGFR1" ENSG00000113721 "Platelet derived growth factor receptor beta" P09619 5 150113837-150155872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Chemotaxis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Sertoli cells: 1267.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 8 "monocytes: 4.1;T-cells: 2.9" "Group enriched" "Detected in some" 4 "ASC diff: 173.0;ASC TERT1: 59.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003842, CAB018144, HPA028499" Enhanced Supported "Golgi apparatus,Vesicles" NA NA 35000000 Vesicles "Golgi apparatus" "CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018" "unprognostic (4.75e-2)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.27e-1)" "unprognostic (5.61e-2)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (2.12e-2)" "unprognostic (2.57e-3)" "unprognostic (6.72e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.87e-8)" "unprognostic (3.13e-3)" "unprognostic (1.25e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (8.11e-4)" 61.8 10.4 8.3 11.0 9.1 0.5 66.1 4.6 10.4 73.1 15.7 6.7 6.9 5.1 44.3 17.3 21.7 26.1 51.7 24.2 8.2 3.9 17.0 4.6 28.9 21.5 7.9 8.1 46.5 7.5 10.4 7.7 46.4 7.7 24.2 6.3 22.9 11.2 19.3 29.8 20.3 11.2 29.8 5.0 19.6 9.2 21.5 6.7 1.4 21.4 16.0 7.3 23.6 35.1 0.4 0.1 0.0 4.1 0.0 2.9 0.6 0.0 0.0 1.0 0.0 173.0 59.9 0.4 6.0 25.1 4.2 7.1 0.6 0.0 0.0 0.8 17.3 2.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.4 24.5 0.0 0.0 27.0 0.0 5.8 0.0 13.5 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 6.8 2.2 2.9 0.3 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 2.9 0.6 0.0 0.4 0.1 0.8 0.1 0.1 0.0 1.3 0.0 0.0 4.1 0.0 0.0 0.6 8.3 9.1 4.6 10.4 8.2 3.9 7.9 8.1 7.7 6.7 0.0 0.6 0.0 0.5 21.3 5.0 13.4 0.0 1.4 0.0 1.8 3.9 0.6 0.0 0.0 0.8 16.2 0.0 0.0 0.0 1.0 68.8 0.6 0.0 1.5 1.4 0.0 0.0 6.7 0.0 4.7 153.1 2.2 23.6 1.0 0.0 74.9 0.1 0.0 191.6 0.0 1.1 1267.6 273.4 1.1 1.5 13.4 0.7 1.0 0.4 0.9 PFKFB1 PFRX ENSG00000158571 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1" P16118 X 54932961-54998534 "Enzymes, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 15.5" "Cancer enriched" "Detected in some" 11 "liver cancer: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 13.9;Hep G2: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.51e-1)" "unprognostic (2.39e-2)" "unprognostic (1.17e-2)" "unprognostic (4.38e-3)" "unprognostic (1.64e-1)" "unprognostic (6.12e-2)" "unprognostic (1.18e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "unprognostic (3.33e-1)" "unprognostic (3.26e-3)" "unprognostic (2.88e-1)" "unprognostic (5.36e-3)" "unprognostic (5.06e-1)" "unprognostic (4.87e-2)" "unprognostic (1.16e-4)" "unprognostic (1.96e-3)" 24.2 0.2 0.1 1.6 0.1 0.1 13.1 0.1 0.2 0.1 1.7 0.1 0.1 0.0 0.1 0.2 0.5 0.0 0.1 0.1 0.1 0.1 0.4 24.4 0.1 1.6 0.1 0.1 0.1 0.6 0.2 0.2 0.1 0.1 0.3 0.2 0.1 1.3 0.1 48.3 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 8.3 0.6 0.2 2.0 1.5 0.1 0.0 0.7 1.3 2.1 0.3 0.3 0.2 0.4 0.6 13.9 0.3 1.0 0.0 0.1 0.2 0.0 0.9 0.2 0.6 0.3 0.1 0.6 0.5 0.1 0.3 0.5 0.4 1.1 0.4 0.1 5.5 0.0 0.1 0.6 0.2 0.6 0.1 0.4 0.0 0.0 1.3 0.1 2.2 0.2 0.7 0.6 0.3 0.4 0.4 0.3 0.5 0.2 0.2 0.0 0.4 0.4 0.3 0.5 1.6 0.2 1.2 0.4 0.0 0.2 0.1 0.5 0.4 0.2 1.1 1.7 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.7 2.1 1.5 0.2 0.0 0.0 0.8 0.0 0.8 0.0 1.3 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.5 0.1 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 PLIN2 "ADFP, ADRP" ENSG00000147872 "Perilipin 2" Q99541 9 19108375-19149290 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 233.1;liver: 139.9" "Cell type enhanced" "Detected in many" 12 "Syncytiotrophoblasts: 1518.0" "Group enriched" "Detected in all" 5 "liver cancer: 63.0;renal cancer: 136.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 83.5;eosinophil: 76.1" "Group enriched" "Detected in all" 5 "granulocytes: 83.5;monocytes: 21.1" "Group enriched" "Detected in many" 5 "ASC diff: 201.9;HHSteC: 174.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016607, CAB037331" Supported Supported "Lipid droplets" NA NA "Lipid droplets" "CAB037331: , HPA016607: AB_2669403" "unprognostic (2.02e-1)" "unprognostic (4.30e-2)" "unprognostic (3.47e-1)" "unprognostic (2.55e-2)" "unprognostic (2.41e-2)" "unprognostic (3.08e-2)" "unprognostic (3.02e-2)" "unprognostic (3.28e-3)" "unprognostic (4.92e-2)" "unprognostic (4.66e-2)" "unprognostic (1.40e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.14e-3)" "unprognostic (7.89e-2)" "prognostic favorable (2.16e-4)" "unprognostic (1.77e-1)" 233.1 17.4 1.8 6.5 2.8 14.9 98.9 1.1 3.2 11.2 47.4 2.0 5.4 28.4 7.7 7.8 6.2 6.1 10.9 37.0 1.7 1.6 36.0 139.9 18.3 9.6 2.2 1.2 37.5 4.5 2.0 4.7 46.4 3.0 17.1 3.5 5.9 8.5 4.5 75.7 13.5 61.6 6.8 3.1 9.8 5.5 16.5 2.4 4.4 8.8 4.0 4.6 63.2 102.9 3.2 8.6 83.5 21.1 2.0 11.5 11.8 0.0 2.8 3.3 2.4 201.9 27.5 36.6 9.3 7.2 5.7 6.5 4.4 0.6 0.0 0.1 19.0 36.6 0.3 3.2 0.0 9.8 11.8 0.0 15.5 0.4 16.5 174.9 1.8 28.4 29.1 3.3 13.9 0.0 4.6 7.0 0.0 2.8 3.4 22.0 0.8 4.2 6.3 4.4 0.0 5.7 10.2 1.5 0.1 0.0 10.8 0.2 5.4 4.3 1.1 9.1 4.4 2.2 4.1 11.0 0.0 1.7 8.8 0.0 2.0 2.0 6.2 0.0 3.1 0.9 83.5 14.9 76.1 11.5 19.7 10.0 3.2 10.1 8.2 8.6 2.9 9.9 8.4 0.9 2.0 21.1 1.0 9.6 11.8 1.8 2.8 1.1 3.2 1.7 1.6 2.2 1.2 3.0 2.4 17.9 63.4 41.2 370.9 183.2 2.2 58.6 89.2 24.1 69.4 12.2 0.0 148.6 23.2 64.2 3.3 59.0 94.5 116.8 13.9 494.8 114.6 78.6 397.7 505.9 405.3 11.1 14.3 96.3 188.8 7.8 36.8 170.1 82.7 39.7 15.4 42.6 57.0 23.0 65.0 211.8 4.8 12.9 104.0 7.7 23.3 94.9 1518.0 59.8 29.9 214.1 PPP1R1A ENSG00000135447 "Protein phosphatase 1 regulatory inhibitor subunit 1A" Q13522 12 54575387-54588659 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 67.0;skeletal muscle: 227.2" "Cell type enriched" "Detected in many" 5 "Distal tubular cells: 1142.3" "Cancer enhanced" "Detected in many" "liver cancer: 17.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Group enriched" "Detected in some" 4 "ASC diff: 6.5;NTERA-2: 21.2;RPTEC TERT1: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB007811, HPA041542" Approved NA NA "CAB007811: AB_598171, HPA041542: AB_2677542" "unprognostic (6.39e-3)" "unprognostic (2.61e-1)" "unprognostic (4.61e-3)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (8.19e-3)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.04e-2)" "unprognostic (2.71e-3)" "unprognostic (1.76e-3)" "unprognostic (2.88e-3)" "unprognostic (7.68e-3)" "unprognostic (2.17e-1)" "unprognostic (8.49e-3)" "unprognostic (7.49e-2)" 67.0 2.1 9.9 1.6 33.2 1.3 51.8 2.2 8.2 1.6 4.0 2.9 0.5 2.2 1.7 1.8 4.3 1.6 1.9 34.6 6.6 3.7 35.4 27.5 1.3 1.4 6.4 4.8 3.3 5.6 3.9 0.1 1.2 4.8 2.9 1.8 0.1 3.1 2.3 227.2 1.3 2.4 2.3 2.7 1.3 4.7 1.7 7.8 0.0 1.4 16.6 1.4 1.4 4.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.9 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 21.2 0.0 0.0 0.0 0.0 0.1 23.4 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 33.2 2.2 8.2 6.6 3.7 6.4 4.8 4.8 7.8 0.0 0.0 1.9 0.0 0.1 0.7 215.5 2.5 0.0 0.0 17.4 0.0 0.0 1142.3 2.9 1.5 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 215.6 0.7 106.5 2.4 6.2 3.8 1.3 1.1 0.0 0.0 0.0 0.3 1.4 4.1 0.0 1.1 55.9 2.9 0.0 9.8 0.0 1.7 0.3 0.0 0.0 0.5 0.1 PRELP "prolargin, SLRR2A" ENSG00000188783 "Proline and arginine rich end leucine rich repeat protein" P51888 1 203475828-203491352 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 183.7" "Group enriched" "Detected in many" 4 "Fibroblasts: 65.7;Leydig cells: 93.2;Melanocytes: 182.2;Muller glia cells: 156.5;Peritubular cells: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "ASC diff: 18.7;BJ: 7.6;fHDF/TERT166: 11.5;SuSa: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA 280000 "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.83e-2)" "unprognostic (6.56e-2)" "unprognostic (2.75e-2)" "unprognostic (1.61e-1)" "unprognostic (2.84e-2)" "unprognostic (3.98e-2)" "unprognostic (2.04e-1)" "unprognostic (2.80e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (5.62e-6)" "unprognostic (2.81e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.02e-4)" 46.7 16.0 6.3 7.7 5.8 1.1 52.3 3.6 5.0 57.4 35.7 3.7 16.8 5.0 45.3 17.8 46.2 29.5 27.4 58.6 7.0 1.8 8.1 7.3 49.9 5.2 6.4 9.5 62.3 6.6 1.8 7.3 8.3 8.6 48.3 6.6 64.6 10.4 52.5 24.5 16.4 17.0 61.8 7.7 22.6 13.5 23.4 3.3 0.0 25.1 16.1 11.5 98.7 183.7 1.0 1.0 4.0 1.2 1.1 0.8 0.6 0.2 0.2 0.5 0.2 18.7 0.5 0.5 7.6 1.0 0.2 0.2 0.0 0.2 1.2 0.7 11.5 0.2 0.7 0.2 0.3 0.3 0.1 0.2 0.4 0.4 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 2.1 0.1 0.4 0.3 0.5 1.4 0.1 0.2 0.5 0.5 0.3 0.1 0.4 0.2 0.5 0.0 0.3 1.1 0.3 0.2 0.2 0.8 5.6 0.3 0.2 0.6 0.5 0.3 0.3 0.1 0.3 0.4 1.2 0.1 0.2 0.5 4.0 1.2 1.7 0.7 1.0 0.8 0.6 0.7 0.5 0.4 1.0 0.7 0.6 2.7 1.1 1.1 1.0 0.6 0.6 6.3 5.8 3.6 5.0 7.0 1.8 6.4 9.5 8.6 3.3 0.0 8.0 0.5 0.9 16.3 2.9 4.3 0.0 2.7 1.2 0.0 2.0 0.0 0.0 0.0 0.6 10.9 0.0 0.0 0.0 0.1 65.7 0.5 4.7 0.0 0.3 1.6 0.0 30.7 0.0 2.3 93.2 1.9 182.2 0.0 0.0 156.5 0.0 0.0 187.7 0.0 4.7 25.8 26.8 2.7 0.8 8.7 0.2 0.0 0.0 0.7 PTGDR "DP, DP1, PTGDR1" ENSG00000168229 "Prostaglandin D2 receptor" Q13258 14 52267713-52276724 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Mast cell degranulation" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.1" "Group enriched" "Detected in some" 5 "T-cells: 31.9;Undifferentiated cells: 11.2" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "pons and medulla: 13.9" "Group enriched" "Detected in many" 5 "gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1" "Group enriched" "Detected in many" 30 "NK-cells: 30.1;T-cells: 25.4" "Group enriched" "Detected in some" 4 "ASC diff: 1.4;HSkMC: 1.6;REH: 2.4;U-138 MG: 1.8" "Low region specificity" "Detected in many" HPA049668 Enhanced NA NA "HPA049668: " "unprognostic (9.32e-3)" "unprognostic (3.31e-2)" "unprognostic (1.00e-2)" "unprognostic (2.04e-3)" "unprognostic (4.80e-2)" "unprognostic (2.70e-2)" "unprognostic (3.11e-3)" "unprognostic (5.00e-2)" "unprognostic (9.38e-3)" "unprognostic (4.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (5.60e-8)" "unprognostic (1.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.02e-2)" "unprognostic (5.89e-2)" 3.9 0.9 0.7 9.6 2.5 1.8 9.3 1.4 1.4 5.5 10.0 0.7 0.9 1.1 4.1 2.2 2.1 2.5 4.9 2.3 0.8 0.8 1.5 1.8 3.4 8.9 1.0 3.5 2.3 0.8 0.8 4.5 0.4 13.9 2.1 12.8 11.2 2.6 3.5 0.9 1.3 2.4 2.0 3.6 10.9 2.0 0.9 0.8 1.8 2.5 0.1 3.1 3.3 3.2 0.0 0.0 0.9 0.1 30.1 25.4 4.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 25.4 0.0 12.7 0.0 3.5 15.2 0.0 0.0 0.6 8.9 0.9 30.1 0.1 0.0 0.0 4.1 0.7 2.5 1.4 1.4 0.8 0.8 1.0 3.5 13.9 0.8 3.0 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 1.2 3.1 2.1 0.0 0.0 0.2 1.7 0.0 4.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 31.9 11.2 0.0 PTGIS "CYP8A1, PGIS" ENSG00000124212 "Prostaglandin I2 synthase" Q16647 20 49503874-49568146 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 88.2" "Group enriched" "Detected in many" 8 "Ito cells: 78.5;Leydig cells: 24.7;Peritubular cells: 98.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 17.8;ASC TERT1: 17.9;U-2197: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009517, HPA014193, HPA052244" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574" "unprognostic (7.68e-2)" "unprognostic (1.90e-1)" "unprognostic (5.09e-3)" "unprognostic (1.38e-2)" "unprognostic (1.80e-2)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (1.29e-2)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (2.45e-2)" "unprognostic (5.22e-2)" "prognostic unfavorable (4.74e-8)" "unprognostic (2.29e-2)" "unprognostic (7.61e-2)" "unprognostic (4.89e-3)" "prognostic unfavorable (9.99e-5)" 18.2 2.5 0.6 8.0 1.3 0.1 28.3 0.2 1.6 23.3 14.6 0.5 6.5 1.7 36.5 21.7 13.2 32.0 36.3 23.8 0.3 0.5 3.0 3.8 7.5 1.6 0.5 0.9 51.2 1.3 0.2 0.5 1.0 1.0 27.2 3.7 3.2 3.7 4.6 7.0 3.2 4.4 88.2 1.4 0.3 8.7 16.2 0.3 0.0 6.7 5.6 1.7 64.2 36.1 1.0 0.8 2.7 0.6 0.8 0.5 0.1 0.0 0.0 0.7 0.0 17.8 17.9 0.2 0.3 2.1 0.0 0.0 0.0 0.0 0.0 7.1 5.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.3 0.0 0.2 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.9 55.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.1 1.0 0.4 0.5 2.7 0.8 0.3 0.8 0.2 0.1 0.6 1.3 0.2 1.6 0.3 0.5 0.5 0.9 1.0 0.3 3.0 2.4 0.0 0.6 3.3 0.8 3.4 0.0 4.0 3.4 3.5 0.0 0.3 0.0 0.4 1.7 3.8 0.0 0.0 0.0 0.1 8.3 0.3 0.0 0.6 0.3 0.0 0.0 78.5 1.5 2.2 24.7 0.7 1.7 0.0 0.0 0.3 0.7 0.0 98.6 0.0 4.6 0.0 2.5 0.7 1.1 4.3 0.2 0.5 0.0 0.6 SERPING1 "C1-INH, C1IN, C1NH, HAE1, HAE2" ENSG00000149131 "Serpin family G member 1" P05155 11 57597387-57614853 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity" "Protease inhibitor, Serine protease inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 693.2" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 749.1;Hepatocytes: 2308.4;Leydig cells: 680.9" "Cancer enhanced" "Detected in all" "liver cancer: 609.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 8.9;intermediate monocyte: 11.0;neutrophil: 32.1;plasmacytoid DC: 28.5" "Group enriched" "Detected in many" 143 "dendritic cells: 28.5;granulocytes: 32.1;monocytes: 11.0" "Group enriched" "Detected in some" 6 "ASC diff: 148.4;ASC TERT1: 76.8;HSkMC: 127.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026161, HPA048738" Supported "Secreted to blood" NA NA 38000000000 "CAB026161: , HPA048738: AB_2680505" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (4.26e-2)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (4.12e-3)" "unprognostic (2.13e-1)" "unprognostic (8.95e-2)" "prognostic favorable (8.03e-4)" "unprognostic (5.92e-3)" "unprognostic (3.76e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.60e-2)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.17e-1)" 88.8 16.3 3.6 18.2 5.4 1.6 75.0 3.8 6.3 62.7 37.8 7.3 16.7 6.2 63.4 58.8 58.3 63.4 61.6 55.5 3.4 3.0 53.4 693.2 73.8 22.4 5.7 4.1 116.4 38.1 8.0 18.4 33.1 14.9 70.3 11.9 82.6 20.7 33.2 36.5 23.1 20.3 38.7 17.3 42.7 30.3 39.2 3.6 1.8 41.5 24.4 16.8 68.7 122.2 0.0 28.5 32.1 11.0 0.1 0.0 2.8 0.0 0.0 5.6 0.0 148.4 76.8 1.0 9.4 6.7 2.0 3.6 0.3 0.0 0.0 11.3 4.8 0.0 0.0 0.0 0.6 1.2 0.0 0.0 4.6 0.0 0.2 19.6 0.2 0.9 127.4 1.9 0.7 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 5.7 0.0 0.0 0.7 0.5 0.0 0.9 0.0 0.0 1.8 0.0 0.0 0.1 5.1 0.1 0.4 0.0 0.3 3.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 8.9 0.1 0.0 11.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 32.1 0.1 4.4 28.5 0.0 2.8 3.6 5.4 3.8 6.3 3.4 3.0 5.7 4.1 14.9 3.6 110.2 95.0 7.0 53.1 67.3 0.6 19.8 749.1 34.8 102.4 150.1 0.0 17.1 36.5 333.2 3.5 154.2 0.0 0.0 39.3 87.1 278.1 25.0 7.0 2308.4 40.1 0.0 0.0 231.4 85.9 8.5 680.9 41.3 86.0 12.6 0.0 52.7 58.0 0.0 215.0 42.4 4.4 265.1 282.5 2.4 3.0 51.9 21.1 39.9 0.0 30.8 SFRP2 "FRP-2, SARP1, SDF-5" ENSG00000145423 "Secreted frizzled related protein 2" Q96HF1 4 153780592-153789120 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 102.5" "Group enriched" "Detected in some" 15 "Basal keratinocytes: 102.6;Fibroblasts: 163.9;Melanocytes: 113.1;Smooth muscle cells: 47.4;Suprabasal keratinocytes: 92.6" "Cancer enhanced" "Detected in all" "pancreatic cancer: 370.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 53.5;ASC diff: 20.3;HSkMC: 33.5;NTERA-2: 74.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA002652 Approved "Intermediate filaments" "Secreted in other tissues" NA NA "Intermediate filaments" "HPA002652: AB_2732394" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (7.21e-3)" "unprognostic (1.80e-2)" "unprognostic (2.73e-1)" "unprognostic (8.80e-3)" "unprognostic (5.71e-3)" "unprognostic (2.62e-2)" "unprognostic (2.79e-1)" "unprognostic (7.47e-3)" "unprognostic (1.44e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (8.56e-6)" "unprognostic (9.29e-3)" "unprognostic (4.72e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.39e-4)" 42.9 4.0 3.4 17.6 1.7 0.2 70.0 1.3 8.0 10.9 20.6 11.3 18.2 4.4 6.4 64.4 51.5 18.5 74.9 42.2 8.5 1.2 1.9 0.2 21.3 2.6 2.8 5.6 7.9 22.5 1.6 23.2 0.3 4.6 33.4 10.8 8.4 23.9 19.5 2.5 26.1 13.7 72.3 5.4 0.3 11.4 13.2 5.0 0.3 29.1 29.4 6.8 102.5 37.4 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 53.5 0.0 20.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.4 1.7 1.3 5.7 8.5 1.2 2.8 5.6 4.6 5.0 3.0 1.1 0.0 0.6 102.6 0.0 0.3 0.0 5.3 3.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 163.9 0.3 1.1 0.0 3.3 0.0 0.0 0.0 0.0 0.2 3.7 2.2 113.1 1.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 47.4 0.0 0.2 92.6 0.1 0.0 0.0 1.0 SVEP1 "bA427L11.3, C9orf13, FLJ13529, POLYDOM" ENSG00000165124 "Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1" Q4LDE5 9 110365251-110579880 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 141.1" "Group enriched" "Detected in some" 6 "Fibroblasts: 33.2;Leydig cells: 38.9;Syncytiotrophoblasts: 56.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 51.6;ASC TERT1: 30.0;BJ hTERT+: 21.1;HHSteC: 18.9;HSkMC: 23.4" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 7 "cerebellum: 31.1" "HPA020610, HPA021520" Enhanced "Intracellular and membrane" NA NA 160000000 "HPA020610: AB_2197021, HPA021520: AB_1855533" "unprognostic (4.47e-2)" "unprognostic (6.01e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-2)" "unprognostic (2.31e-1)" "unprognostic (2.62e-2)" "unprognostic (9.13e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (3.31e-3)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (9.84e-2)" "unprognostic (2.21e-1)" "unprognostic (1.55e-3)" 18.8 2.5 1.0 3.9 1.8 0.0 11.9 6.7 0.9 7.1 8.6 0.5 3.6 0.6 6.1 7.8 4.7 4.4 5.4 4.4 1.1 0.7 2.1 1.5 8.6 5.8 1.1 0.5 4.2 2.7 2.2 0.7 141.1 0.7 4.3 3.1 1.5 2.2 1.3 7.4 3.5 3.3 5.7 0.6 3.4 3.6 4.0 0.9 0.0 3.5 2.3 1.3 9.6 7.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 51.6 30.0 0.0 5.4 21.1 0.4 0.6 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.1 0.3 0.0 0.1 0.0 0.4 0.0 18.9 0.0 1.0 23.4 0.0 4.1 1.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.7 0.0 3.8 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.4 0.8 0.0 2.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 6.7 0.9 1.1 0.7 1.1 0.5 0.7 0.9 0.0 0.3 0.0 0.5 5.0 0.0 1.2 7.6 0.0 0.0 0.0 0.0 7.6 0.0 0.6 0.2 2.1 0.0 0.0 0.2 1.1 33.2 0.2 0.0 0.0 2.7 0.0 0.0 3.1 0.0 0.0 38.9 0.0 6.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.1 1.4 2.9 56.3 0.0 0.0 0.1 TMEM132C "DKFZp761O2018, PPP1R152" ENSG00000181234 "Transmembrane protein 132C" Q8N3T6 12 128267403-128707915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 14.3;Cone photoreceptor cells: 5.9;Leydig cells: 8.3;Peritubular cells: 14.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6;testis cancer: 4.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "gdT-cell: 5.4" "Lineage enriched" "Detected in single" 55 "T-cells: 5.4" "Group enriched" "Detected in some" 6 "AF22: 6.1;ASC diff: 8.7;Daudi: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015633, HPA015984" Approved Centrosome,Cytosol NA NA 110000000 "Centrosome, Cytosol" "HPA015633: AB_1858089, HPA015984: AB_1858088" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (7.34e-2)" "unprognostic (8.60e-2)" "unprognostic (2.37e-1)" "unprognostic (1.99e-3)" "unprognostic (5.48e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.85e-2)" "unprognostic (6.29e-2)" "unprognostic (7.97e-3)" "unprognostic (2.54e-1)" "unprognostic (5.71e-2)" "unprognostic (6.33e-3)" 37.5 4.2 9.6 1.1 7.0 0.8 23.3 5.0 6.6 22.0 2.5 4.2 8.9 1.2 5.9 5.7 4.7 13.4 5.1 3.5 5.0 3.8 1.3 0.8 1.6 2.0 4.9 3.1 7.9 4.1 0.9 0.6 5.1 4.6 3.7 1.3 5.3 2.9 9.1 1.9 2.2 1.4 2.1 3.9 1.1 1.5 2.1 5.4 0.0 1.1 0.9 1.3 3.8 10.5 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 6.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.6 7.0 5.0 6.6 5.0 3.8 4.9 3.1 4.6 5.4 0.0 0.0 0.0 0.0 0.3 14.3 0.7 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 1.7 0.0 0.0 0.4 0.1 0.0 14.2 0.0 2.1 0.0 1.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719310-19773598 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;pituitary gland: 12.6" "Cell type enriched" "Detected in some" 10 "Bipolar cells: 51.1" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 8.8;ASC TERT1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.7 3.7 8.0 0.6 8.6 0.4 0.4 0.3 15.0 1.2 0.6 0.3 0.0 0.4 3.8 1.5 0.5 1.2 0.4 0.4 3.6 10.1 0.6 0.4 0.4 0.4 2.9 7.4 0.4 3.0 0.7 12.6 0.4 5.0 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.4 0.4 2.6 0.5 2.8 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 8.8 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 8.6 0.3 7.3 3.6 10.1 2.9 7.4 5.0 2.8 0.0 0.0 0.0 0.0 0.0 51.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM63 "IRF, MURF-1, RNF28, SMRZ" ENSG00000158022 "Tripartite motif containing 63" Q969Q1 1 26051304-26068436 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Muscle protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 271.4" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 236.2" "Cancer enriched" "Detected in some" 10 "melanoma: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "ASC diff: 10.7;SK-MEL-30: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.10e-1)" "unprognostic (4.80e-4)" "unprognostic (1.45e-2)" "unprognostic (7.52e-3)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (1.01e-1)" "unprognostic (2.16e-2)" "unprognostic (5.90e-2)" "unprognostic (1.33e-2)" "unprognostic (2.32e-1)" "unprognostic (5.58e-2)" 3.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 1.2 1.7 0.0 0.6 38.2 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.5 0.0 3.6 1.0 0.0 271.4 0.6 0.1 0.9 0.1 0.0 0.1 0.1 0.0 0.0 1.7 12.7 0.8 1.2 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.8 0.0 236.2 10.2 0.0 0.0 1.8 0.0 0.4 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 9.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 XG PBDX ENSG00000124343 "Xg blood group" P55808 X 2752048-2816500 "Blood group antigen proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8" "Group enriched" "Detected in some" 8 "Basal keratinocytes: 12.8;Melanocytes: 10.1;Suprabasal keratinocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 2.1;naive B-cell: 1.0" "Lineage enriched" "Detected in single" 21 "B-cells: 2.1" "Group enriched" "Detected in some" 6 "ASC diff: 34.4;ASC TERT1: 25.6;fHDF/TERT166: 16.1;hTCEpi: 23.9;T-47d: 12.9" "Low region specificity" "Detected in all" NA NA "prognostic unfavorable (4.25e-4)" "unprognostic (1.69e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (3.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" "unprognostic (8.62e-2)" "unprognostic (7.21e-2)" "unprognostic (2.30e-1)" "unprognostic (8.10e-6)" "unprognostic (3.96e-3)" "unprognostic (7.98e-2)" "unprognostic (5.83e-3)" "unprognostic (6.77e-3)" 8.9 0.0 0.3 0.3 0.6 0.8 9.1 0.5 0.6 22.8 0.3 0.3 0.3 0.0 2.6 0.3 7.1 0.6 3.0 1.2 1.4 0.0 1.3 0.3 0.3 0.3 0.6 0.3 1.1 0.3 0.0 0.3 18.4 1.9 0.5 0.0 0.3 4.1 0.4 1.4 25.8 0.3 0.3 4.2 0.3 0.1 0.3 0.3 0.3 0.9 0.3 2.4 1.2 7.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 25.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 23.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.1 1.7 0.0 12.9 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.6 1.4 0.0 0.6 0.3 1.9 0.3 0.0 0.0 0.0 0.6 12.8 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.5 19.2 0.5 0.0 0.0 0.1